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INSTITUTIONAL MICROBIAL ANALYSIS OF ODONTOGENIC 
INFECTIONS AND THEIR EMPIRICAL ANTIBIOTIC 
SENSITIVITY 
Introduction 
Most purulent orofacial infections are of odontogenic origin. Odontogenic 
infections are the sequel to dental caries, periodontitis etc. Odontogenic infection ranges 
from periapical abscesses to superficial space and deep neck infection. In addition to 
systemic toxicity it also causes advanced complications such as suppurative mediastinal 
spread, an airway obstruction, retropharyngeal pleuropulmonary suppuration, 
haematogenous dissemination to heart valves, prosthetic devices, other metastatic foci, 
jugular vein thrombosis, mediastinal involvement, pericarditis, pneumonia, emphysema, 
arterial erosion, meningitis, and extracranial or intracranial extension of infection.  
These infections continue to be a very significant cause of morbidity and 
mortality, hence early diagnosis and institution of immediate aggressive therapy is often 
essential. Hence knowledge of potential spectrum of pathogens as well as the 
antimicrobial susceptibility and regional resistance status is important for rational 
medicinal regime. Empiric antibiotics were administered before the culture and 
sensitivity tests results are available and specific antibiotics are selected based on the 
culture and sensitivity test results. Cultural analysis still remains the backbone of the 
clinical practice and the findings of a number of the prospective and the retrospective 
studies given a valuable insight into the bacteria which are often present. Regular study 
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of microbiological flora of abscess should be necessary to monitor adaptations and 
changes in the bacterial resistant strains. 
Aims & Objectives 
The aim of the study was to qualitatively evaluate different aerobic and anaerobic 
microbiota with their antibiotic sensitivity in head and neck space infections of 
odontogenic origin. To understand the efficacy of currently used empirical antibiotics in 
the management of odontogenic infections. 
Methodology 
All the Patients with head and neck fascial space infections of odontogenic origin 
who had not taken antibiotics were selected for the study. The site was anesthetized by 
local anesthetic (2% lignocaine with adrenalin). Pus sample were collected by transport 
cotton swab stick directly from the site for aerobic culture and also aspirated from the site 
and transferred to the Brain heart infusion broth transport medium for anaerobic culture. 
And it was sent immediately for aerobic and anaerobic culture. The culture was done in 
the Nutrient agar medium, Blood agar medium and MacConkey agar medium. The gram 
staining reaction is used to identify the pathogens in specimens and cultures by their 
Gram reaction and morphology. After material is dispended to culture media and 
incubated for 24 to 48 hours will visualize colonies of grown organism. The anaerobic 
incubation was done in an anaerobic jar. Then all sets of plates will apply biochemical 
tests to identify the genus and species of bacteria. Then the grown colonies of organism 
are spread over the Mueller Hinton Agar media plate. Labelled antibiotic discs are placed 
over the grown colonies of organism on the Mueller Hinton Agar media plate by the help 
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of sterilized forceps. This plate will be again incubated for 12 hours to 24 hours at 37oC. 
A zone of inhibition is appeared surrounding the antibiotic disc indicates the sensitivity 
of the organism to the particular antibiotic and the zone of inhibition is  measured by the 
help of WHO quality control Chart to access the sensitivity of above mentioned discs. 
Results 
In this study out of 142 patients,  125 cases organisms were isolated and taken up 
for the study, Out of 125 cases, 29 (23.2%) Aerobic organisms, 36 (28.8%) anaerobic 
organisms and 60 (48%) mixed organisms were isolated. Streptococcus viridans and was 
the most common aerobic organism isolated followed by Staphylococcus aureus. 
Peptostreptococcus and was the most common anaerobic organism isolated followed by 
Bacteroides. Streptococcus viridians with Peptostreptococcus was the most common 
mixed organism isolated followed by Staphylococcus aureus with Peptostreptococcus. 
Amoxicillin was the most commonly used empirical drug in all cases and showed highest 
resistance for all the aerobic anaerobic and mixed organisms. Among the Macrolide 
group, organisms were least sensitive to Erythromycin and higher resistant. Among the 
board spectrum antibiotics, organisms showed highest sensitivity and least resistance to 
Doxycyclin.  Among the miscellaneous group, Linezolid was sensitive to all the aerobic, 
anaerobic and mixed group of organisms. Metronidazole showed sensitive to the entire 
anaerobic group. Clindamycin showed sensitive to the entire aerobic group. Organisms 
showed highest sensitivity towards Ofloxacin and Levofloxacin. Cefixime and 
Cefotaxime were showed highest Sensitivity among cephalosporins group. 
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Summary and Conclusion                         
According to the study there should be substitution of miscellaneous group of 
antibiotics such as Linezolid, or Clindamycin, third generation cephalosporins such as 
cefixime, cefotaxime, and fluroqunolones such as Ofloxacin and Levofloxacin for 
Amoxicillin in the empirical management of deep fascial space infections. Hence 
successful management of head and neck fascial space infections of odontogenic origin 
can be achieved by appropriate surgical intervention  to establish drainage ,good overall 
supportive care of the patient, gram staining of purulent exudates  to provide  immediate 
information needed for the rational selection of an antibiotic  and in vitro microbiological 
culture and antibiotic susceptibility.  
Specificity of empirical antibiotic therapy could be improved with good 
knowledge about the pathologic flora in the locality. This will help in administration of 
appropriate antibiotics instantaneously to control the infection. This will counter the 
delay in identification of the causative agent and specific antibiotic therapy.  
It can be concluded that the knowledge about the pathologic flora involved in 
head and neck infection in a locality and their sensitivity and resistance to commonly 
used antibiotics will help the clinician in administering appropriate antibiotics at the 
earliest phase of infection, which will adequately control the infection and hence 
minimizes the morbidity.  
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Historically, the potential for a dental abscess to spread causing severe sepsis and 
death has been known since antiquity, although the role of bacteria in this process was 
not recognized until the turn of 20th century1.  Head and neck space infections are known 
to be commonly of odontogenic origin. Earlier in the start of century neck spaces thought 
to be arise from tonsillitis, post operative tonsil wound, tuberculoid tonsil, tuberculoid 
cervical gland, caries of  cervical vertebrae and syphilis of throat. These factors were 
considered as the immediate predisposing causes. Modern literatures point toward the 
deep neck infections arising from odontogenic infections. By the turn of 20th century, 
dental infections were associated with mortality rate of 10-40%1.  When the Bills of 
Mortality began listing the causes of death in the early 1600s, ‘teeth’ were listed as the 
5th or 6th leading cause for death1 
Most purulent orofacial infections are of odontogenic origin2. Odontogenic 
infections are the sequel to dental caries, periodontitis etc. Odontogenic infection ranges 
from periapical abscesses to superficial space and deep neck infection. Deep neck and 
mediastinal abscess are rare but serious complication of odontogenic infections. But the 
spread of odontogenic infection accounts for 57% deep neck abscesses1. In addition to 
systemic toxicity it also causes advanced complications such as suppurative mediastinal 
spread, an airway obstruction, retropharyngeal pleuropulmonary suppuration, 
haematogenous dissemination to heart valves, prosthetic devices, other metastatic foci, 
jugular vein thrombosis, mediastinal involvement, pericarditis, pneumonia, emphysema, 
arterial erosion, meningitis, and extracranial or intracranial extension of infection3,4,  
Carotid artery erosion is a devastating complication that can involve the common, 
internal, or external carotid branches. Internal jugular vein thrombosis is the most 
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common vascular complication. It is characterized by shaking chills, spiking fevers, 
tenderness, and swelling at the angle of the mandible or along the sternocleidomastoid 
muscle5. Internal jugular vein thrombosis may produce bacteremia, circulating septic 
thrombi with distant infection, or pulmonary embolism5, 6, 7. These complications clearly 
indicate the potentially serious nature of orofacial infections.  
These infections continue to be a very significant cause of morbidity and 
mortality, hence early diagnosis and institution of immediate aggressive therapy is often 
essential.  Knowledge about the potential spectrum of pathogens as well as the 
antimicrobial susceptibility and regional resistance status is important for rational 
medicinal regime. 
It is well established that odontogenic infections are not caused by a single 
organism; instead these infections are polymicrobial in nature1, 8, 9, 10, 11, 12, 13, 14, 15, 16 . 
These infections consists of various facultative anaerobes, such as the Streptococci 
Viridans group, the Streptococcus Anginosus group, and strict anaerobes, especially 
anaerobic cocci, such as Peptostreptococci, Prevotella, Fusobacterium species and 
Bacteroides1. Most of these infections were identified as mixed infections predominated 
by anaerobes of both cultivable and uncultivable origin. The flora associated with such 
infections is very much complex and it generally reflects the combined influence of the 
indigenous oral flora and the unique flora of the underlying condition8.  
Therapeutic strategies must be targeted at the degree of infection and host 
immune status. Some of them would require aggressive management, where as others 
require less aggressive modalities. The criterion for choosing an appropriate antibiotic or 
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its parent group is largely dependent on the type of organism involved and its virulence 
factor. Formulations in terms of specific culture guided therapy must be preceded by 
empirical therapy to limit the spread of infection. 
           Empiric antibiotics were administered before the culture and sensitivity tests 
results are available and specific antibiotics are selected based on the culture and 
sensitivity test results. Allergic or toxic reaction, swelling, temperature, and white blood 
cell count to decline after at least 48 hours of intravenous administration of pencillin, and 
a post operative CT scan shows inadequate surgical drainage are the reported reasons for 
therapeutic failure of pencillin. These findings suggest a correlation between infection 
severity and pencillin resistance and are the basis for the recommendation of clindamycin 
as the empiric antibiotic of choice in odontogenic infections17. 
Resistance may be either inherent or can be acquired by the processes of genetic 
mutation or gene transfer18. The mechanisms of acquired resistance fall into one of the 
five categories, although bacteria may employ more than one mechanism (i). Enzymatic 
modification or destruction of the antibiotic, (ii). Reduced antibiotic uptake into the 
bacterium (iii). Increased efflux of antibiotic from the bacterium. (iv). Alteration or 
production of a new target site (v). Over expression of the drug target17.  Literature 
reports that the molecular biology of the antibiotic resistance by any one of the four ways. 
(1). Alteration of the drugs target site (2) Inability of the drug to reach its target. (3) 
Inactivation of the antimicrobial agent. (4) Active elimination of the antibiotic from the 
cell17,18. 
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 “Bacteria are cleverer than men” as they have the capacity to adapt in every 
environmental niche on this planet and now adjusting to a world laced with the 
antibiotics19. To combat the penicillin resistance, the synthetic antibiotics were 
synthesized, however resistance has also developed to these newer synthetic drugs19. The 
treatment of odontogenic infection is based upon three fundamental elements that are 
recognition of airway compromise, surgical intervention, and the administration of the 
appropriate antibiotic20. In most of the cases the antibiotics given are empirical and based 
upon the particular clinical condition of the patient.  It may lead to inadequate treatment 
and development of bacterial resistance and multiple resistances. 
Identifying the pathogen may be determined scientifically in the laboratory where 
the organisms can be isolated from tissue, pus, or blood. Antibiotic therapy is then either 
initial or definitive, and depending upon whether the organism is even identified 
precisely. Cultural analysis still remains the backbone of the clinical practice and the 
findings of a number of the prospective and the retrospective studies given a valuable 
insight into the bacteria which are often present1. Efforts made to identify the causative 
pathogens involved in the development of dental abscess in the past have been hampered 
by the inappropriate methods of sampling.  
Microorganisms involved in infections can reproduce very rapidly and microbes 
such as bacteria can also freely exchange genes by conjugation, transformation and 
transduction between widely divergent species17, 18.  This horizontal gene transfer 
coupled with high mutation rate and may alter by means of genetic variation which 
allows micro organisms to swiftly evolve (via natural selection) to survive in new 
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environment. This rapid evolution is important in medical field and has lead to recent 
development of super bug- pathogenic bacteria that are resistant to modern antibiotics. 
And also antibiotics were used indiscriminately and were prescribed even in mild 
infections and mild injury cases without knowing the chemotherapeutic susceptibility of 
microbes, this led to a challenging problem and development of more virulent strains of 
microorganisms which were more infectious and were resistant to many antibiotics, 
hence much more difficult to treat. 
Therefore regular study of microbiological flora of abscess should be necessary to 
monitor these adaptations and changes in the bacterial resistant strains. More over on 
reviewing the literature it was found that lesser studies have been conducted on Indian 
population to list the common pathogens causing orofacial infection in our region. In 
India most of the patients suffering from orofacial infection are of low socio economic 
status with poor oral hygiene, undernourished or malnourished having below average 
autoimmune resistance and are deprived of proper oral hygiene. Another point is that 
without proper medical advice patients do take medication on their own as the antibiotics 
are also made available easily without appropriate licensed medical practitioner’s 
prescriptions, which may contribute to the said problem. Under circumstances it becomes 
need of time to explore the resistance developed mechanism and its allied concerned 
problem so as to decide right medicinal therapy. Considering above facts this study has 
been designed to obtain valuable information of the laboratory data regarding the 
microbiology and antibiotic susceptibility of microorganisms causing head and neck 
space infections of odontogenic origin in our population. 
Aims & Objectives 
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AIM 
The aim of the study was to qualitatively evaluate different aerobic and anaerobic 
microbiota with their antibiotic sensitivity in head and neck space infections of 
odontogenic origin. To understand the efficacy of currently used empirical antibiotics in 
the management of odontogenic infections. 
 
OBJECTIVES  
The objectives of the present study were: 
1. To identify the causative aerobic and anaerobic micro- organisms responsible for 
head and neck fascial spaces infections. 
2. To evaluate the resistance against empirical antibiotics used in the treatment of 
head and neck space infections. 
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Phillip H. Mann in 1960 conducted a study of identification and differentiation 
of culture of 26 coagulase positive strains of Staphylococcus Aureus and simplified by 
bacteriophage typing from a two hundred carious teeth from 200 patients. He has 
reported both the bacteriophage patterns and the susceptibility to penicillin, 
oxytetracycline, and oleandomycin (matromycin), Sixteen of the 26 coagulase-positive 
strains were non-typable or resistant to lysis by all the phages. Of the 25 coagulase-
positive strains, 18 were susceptible to oxytetracycline, 25 to penicillin, and all to 
oleandomycin. 
D. E. Hunt et al in 1970 conducted an in vitro study of antibiotic sensitivity of 
oral micro organisms to Actinobolin using a paper disk-agar diffusion method for 
inhibitory activity against cariogenic streptococcal strains, mixed microbial cultures, 
bacteria, and yeasts. The presence of zones of growth inhibition around the disks used as 
the parameter for the Actinobolin antimicrobial activity, and found that Actinobolin has 
in vitro antimicrobial activity against 9 cariogenic streptococci and 8 mixed cultures and 
a limited spectrum of gram negative and positive bacteria and yeasts, The organisms were 
highly sensitive to inhibition by actinobolin, and suggests that this antibiotic may be 
useful as a cariostatic agent.  
Charles B. Sabiston et al in 197437 reported a research project to identify the 
types of bacteria present in abscess and their antibiotic sensitivity patterns. He found that 
Fusobacteriem nucleatum present in 7 of the 8 abscesses, Bacteriodes were present 4 out 
of 8 cases and Facultative Streptococci were isolated from 6 of 8 cases. Species of 
Peptostreptococcus, Lactobacillus, Actinomyces and gram negative facultative rods 
occurred in 2 cases. S. Epidermidis were found in 1 case. But the patients were not 
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responding to the pencillin therapy. Clindamycin was useful in treating the infections 
caused by pencillin resistant strains of Bacteriodes and anaerobic infection.  
J. E. Turner, et al in 197533 conducted a study and determined the prevalence of 
bacteria associated with soft-tissue abscesses secondary to dental caries in 66 patients 
using aerobic and anaerobic culture and in vitro antibiotic susceptibility testing. 
Streptococcus viridans was the predominate organism and isolated from 42 (70 %) of the 
viable exudates, including 36 (%) in pure culture. Streptococcus viridans was susceptible 
to all antibiotics used in dental practice, except tetracycline. 8 (19 %) isolates of 
Streptococcus viridns were resistant to tetracycline. Streptococcus viridans were resistant 
to 24 (57%) of Kanamycin and 19(45%) of Gentamycin.  Staphylococcus Epidermidis 
and Staphylococcus Aureus were present in 6 (11 %) and 3 (6 %) cultures, respectively. 3 
(6 %) of the pure cultures produced anaerobic growth. 2 of the 5 cultures specifically 
submitted for anaerobic culture produced anaerobic growth, and in both cases the species 
was Actinomyces. Mixed cultures (revealing more than 1 organism) accounted for 8 (12 
%). A lesser degree of resistance was noted among the Staphylococci to tetracycline, 
erythromycin, ampicillin, kanamycin, gcntamicin, methacillin, and clinclamycin.  
Bartlett and Gorbach in 197549 conducted a study among a total of 84 patients, 
with aspiration pneumonia and primary lung abscess. 49 patients were treated with 
pencillin G and 35 were treated with clindamycin. The predominant organisms were 
peptostreptococci, peptococci, B.Melaninogenicus, fusobbacteria and bacteroids fragilis, 
majority of the anaerobic bacteria were sensitive to pencillin G. There were only 2 
failures among 49 patients receiving pencillin G. Clindamycin were equally effective in 
anaerobic pulmonary infections. Author pointed out, it is not necessary to eliminate every 
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bacterial species in mixed cultures to achieve the result. And showed the example of 
infections where the penicillin therapy remains effective even in the presence of 
penicillin resistant Bacteriodes fragilis. This is due to the fact that by eliminating the 
other pathogens; the microenvironment is altered making it favorable for penicillin. 
Authors further added that successful treatment of infection depend as much on the 
environment either by the debridement or drainage of the infected tissue as well as by 
antimicrobial usage aimed at eradicating the causative organisms. 
A. G. HELSTAD et al in 1977 conducted a comparative study evaluating the 
ability of the three widely used transport systems: (i) aspirated fluid in a gassed-out tube 
(FGT), (ii) swab in modified Cary and Blair transport medium (SCB), and (iii) swab in a 
gassed-out tube (SGT), For maintaining the viability of aerobic anaerobic and facultative 
bacteria.  25 aspirated specimens from clinical infections cultured and evaluated the 
recovery of anaerobic, aerobic, and facultative bacteria in transport tubes were held at 
25°C and semi-quantitatively sampled at 0, 2, 24, and 48 hours. yielded 75 anaerobic 
strains and 43 isolates of facultative and 3 of aerobic bacteria. Only one anaerobic isolate 
was not recovered in the first 24 hours only in the SGT. At 48 hours, 73 anaerobic strains 
(97%) were recovered in the FGT, 69 (92%) in the SCB, and 64 (85%) in the SGT.  
Robin Woods in 197834 reviewed the current antibiotic sensitivity patterns of 
bacteria isolated from 140 cases of acute dental pyogenic infections and the types of 
bacteria associated with these infections and their antibiotic sensitivity patterns are 
discussed and related to earlier reports. The incidence of antibiotic allergy, the principal 
contraindication to the use of certain antibiotics, has been assessed and appropriate 
alternative antibiotics are considered. And further, to evaluate several new 
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chemotherapeutic preparations. He found that the most frequently isolated bacteria from 
pyogenic lesions are streptococci (80 %). There were also a substantial number of (13.6 
%) staphylococci, and 6.4 % of Gram negative bacteria. Penicillin remains the first 
choice for treatment of streptococcal infections and for those for whom penicillin is 
contraindicated, erythromycin is the alternative. The penicillinase resistant penicillin 
cloxacillin is the treatment of choice for staphylococcal infections, although co-
trimoxazole appears more effective. Cephalosporins are effective against staphylococci 
and Gram negative bacteria as well as most of streptococci encountered in the dentistry.  
Boon JR et al in 1982 conducted an experimental study and found out the 
benefits of adding clavulenic acid to amoxicillin. The distribution of amoxicillin 
clavulenic acid combination in infected animals after administration of amoxicillin 
clavulenic acid was evaluated by the measurement of concentrations of substances 
present in the specimens collected at the sites of infection and showed that both the 
amoxicillin and clavulenic acid is well distributed in the animal body and present in 
significant concentrations at various sites of infection. The ability of clavulanic acid to 
protect amoxicillin in vivo was confirmed by the efficacy of amoxicillin-clavulanic acid 
formulations in the treatment of infections.  
James J. Crawford35 et al in 1983 described about the Infections of the 
Orofacial Tissues, types of Infection, and the types of Bacteria in Pyogenic Orofacial 
Infections, infection Management, and choosing the Antibiotic Therapy.  Most bacteria in 
odontogenic or oral infections belong to anaerobic species includes a oral streptococci 
and anaerobic species, especially the Bacteroides, Fusobacterium, anaerobic cocci, and 
Actinoniyces species, are the most common agents of pyogenic submucosal orofacial 
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infections. Management includes drainage and debridement. The Decisions to use 
Antibiotics, duration of therapy, the reasons of Antibiotic therapy failure and the 
Common Errors in Antibiotic Therapy were described.  
Michael A. O. Lewis et al in 1988 reported that the antibiotic susceptibility of 50 
acute dento-alveolar abscesses were determined by testing of the primary cultures of pus 
and secondary cultures of individual isolates, they used a comparative disc method.  The 
sensitivity reports obtained by the primary testing agreed with that of secondary tests for 
47 (94%) of the abscesses were studied. primary testing of pus samples aspirated from 
acute dentoalveolar abscess is reliable and can provide the clinician with antibiotic 
sensitivity results more rapidly than conventional secondary testing, especially when 
slow growing anaerobes are involved. Which yielded a total of 166 bacterial strains was 
studied.  4 of the specimens were polymicrobial with a mean of 3.3 bacterial strains per 
sample; 20 (40%) of the abscesses revealed strict anaerobes, 3 (6%) revealed facultative 
anaerobes, but 27 (54%) revealed a mixture of both types of bacteria. Since slow-growing 
strict anaerobes, particularly Bacteroides species and anaerobic gram-positive cocci, were 
frequently isolated from acute dentoalveolar abscess a reliance on purely secondary 
sensitivity testing would result in a delay of 4-5 days before susceptibility information 
could be available.  
Y. Gill and C. Scully in 199014 described that, anaerobes play a major role in 
odontogenic infections and the most common microbial isolates are Bacferoides, 
fusobacteria, peptococci, peptostreptococci and viridans streptococci. Drainage should be 
established where possible. Penicillin is still the drug of first choice with metronidazole a 
good alternative. Nevertheless, not all clinicians are aware of current views and, 
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therefore, this article is a state-of-the-art review for practicing clinician of microbiology 
and antimicrobial therapy of orofacial odontogenic infections.  
M.A.O. Lewis et al 199012 examined the findings of microbiological studies of 
acute dento-alveolar abscess and identified the likely pathogens and their sensitivity to 
antimicrobials. He found that the microbial flora is usually polymicrobial in acute dento 
alveolar abscess involving strictly anaerobic Gram- positive cocci, facultative anaerobic 
Gram- positive cocci, and strictly anaerobic Gram-Negative bacilli. Choice of 
antimicrobial therapy is phenoxy methylpencillin 250mg 6th hourly, for those with 
hypersensitivity to pencillins, erythromycin 250 mg 6th hourly or amoxicillin 250mg 6th 
or 8th hourly, recommendation of alternative therapy such as metronidazole, orinidazole, 
cefotetan, cefadroxil, clindamycin, and high dose amoxicillin if isolation of occasional 
strains of pencillin resistant Bacteroides species has resulted.     
Brook I et al in 19918 conducted a study which includes 39 patients with 
periapical abscess. Aspirates of pus were taken and studied for aerobic and anaerobic 
bacterial growth. Bacterial growth was presented in 32 specimens includes 78 isolates ( 
55 anaerobic and 23 aerobic and facultative organisms).  Predominant organisms 
identified are Streptococcus spp (20), Bacteroides spp. (23 isolates, including 13 
Bacteroides melatiinogenicus group)., anaerobic cocci (18), and fusobacterium spp (9). 
Beta-lactatnase-producing organistns were recovered and suggest that the polymicrobial 
nature and presence of anaerobic bacteria in periapical abscess. 33% of beta-lactamase in 
the abscess reveals that resistance of pencillin and the requirement of other antimicrobials 
such as clindamycin chloramphenicol, carbencillin, cefoxitin imipenem. 
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Harold C. Neu et al in 1992 20 reported about the mechanism of resistance and 
mechanism of action of different anti microbial agents and their action on aerobic and 
anaerobic species. He describes that the Bacteria have become resistant to antimicrobial 
agents as a result of the exchange of genetic material via plasmids and transposons or 
chromosomal changes. Mechanisms of resistance of Streptococcus pneumoniae, 
Streptococcus pyogenes, staphylococci, Enterobacteriaceae and Pseudomonas families, 
Haemophilus influenza, Neisseria and Moraxella, Enteric Pathogens and Anaerobic 
Bacteria to antimicrobials were described. Mechanisms to overcome the bacterial 
resistance ranged from obvious hygienic practices to stop the spread of bacteria and to the 
synthesis of agents with improved antimicrobial activity should be adopted in order to 
limit the bacterial resistance. 
Vejayan Krishnan et al in 19934 described the management of potentially life-
threatening infections and to establish the protocol for the treatment. This study reviewed 
50 infections treated over a 3-year period. The most frequent cause for the infection was 
odontogenic (43 patients). Clindamycin was the antibiotic of choice used at dosage of 
900 mg every 8 hours IV or 300 mg every 6 hours orally and it was used in 36 patients. 
Penicillin.G was used in dosages of 2 to 4 million units every 4 to 6 hours intravenously 
or 500 mg every 6 hours orally in the remainder of patients. Alpha-hemolytic 
Streptococcus was the most commonly isolated organism. Resistant organisms have 
developed due to its long and widespread use. Clindamycin became preferred antibiotic 
for empiric therapy in this study. A protocol for the management of maxillofacial 
infections is described. The results revealed rapid resolution of the infections by adhering 
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to fundamental principles of management: recognition of airway compromise, surgical 
intervention, and the administration of the appropriate antibiotic.  
Daniel H. Fine et al in 1994 described the importance of the microbial 
surveillance is explained in 3 clinical cases. Each of the case demonstrated a continued 
lack of response to conventional periodontal therapy. Repeated bouts of periodontal 
abscess formation and bone loss have occurred over a 3 to 4 year period, despite 
numerous surgeries supplemented with antibiotics. As a result, patients were termed 
refractory to treatment and extensive microbiological analysis and sensitivity testing was 
done, Actinobacillus actinomycctemcomitans was identified and Tetracycline resistant, 
Amoxicilhn sensitive, Actinomycetemcomitans was discovered from first case, 
Temafloxicin led to elimination of Staphylococcus aureus in second case. And in the 
third case reveals the poiymicrobial nature of the disease-associated plaque would most 
probably have been uncovered eventually by the newer methods such as fluorescent 
antibody identification and DNA probe identification (FA and DNA probes).  Following 
Administration of the appropriate antibiotic and conservative therapy consist of several 
sessions of scaling and root planning, each of the cases demonstrated a dramatic 
remission of disease progression. No further breakdown has been seen for a minimum 
period of 2.5years. These cases support the usefulness of microbial identification coupled 
with antibiotic sensitivity as an adjunct to conventional conservative periodontal therapy. 
Gady Har-El et al in 19949conducted retrospective study on 110 patients with 
diagnosis of different types of abscess. The most common type of organisms involved 
are, Streptococcus viridians (40.9%), Staphylococcus aureus (27.3%), Streptococcus 
epidermidis (22.7%) and Bacteriodes (17%) and anaerobes accounts for 40% of the 
Review of Literature 
 
  15 
 
positive cultures were Bacteroides. Group-A Beta-Hemolytic streptococci were found in 
6.8% and gram-negative aerobic organisms such as Escherichia coli Proteus, and 
Pseudomonas were found in less than 6% of cultures, the most common regimen was 
penicillin G and an anti-staphylococcal drug. Clindamycin or metronidazole was used in 
penicillin allergic patients. Other combinations or a single broad spectrum drug therapy, 
such as, ticarcillin was used in less than a third of the patients. 
Bridgemen A. et al in l99513 reviewed 107 cases of acute maxillofacial 
infections, aerobic and anaerobic microbiological study has been conducted in 81 cases, 
of which 98% yielded growth, majority were mixed infections. Mixed oral flora including 
aerobic and anaerobic streptococci alpha-haemolytic streptococci, Bacteroides, 
Actinomyces israelii  Methicillin-resistant Staphylococcus aureus (MRSA) was the only 
isolate in five cases, beta-lactam and a nitroimidazole were the most commonly adopted 
regimen, crystalline penicillin 2 million units 4 to 6 hourly with metronidazole500 mg 8 
hourly. Antimicrobials were prescribed empirically at the time of presentation and altered 
according culture and susceptibility test results, and dependent on the patient’s progress. 
Authors stated that penicillin is the drug of choice, because it is inexpensive, and 
bactericidal for majority of bacterial strains in odontogenic infections. Also stated that 
bacterial resistance to penicillin has emerged among the strains of alpha haemolytic 
Streptococci, Bacteriodes species and therefore has encouraged the use of metronidazole. 
They also quoted that in current series 81 (75.7%) patients received combination of 
penicillin and metronidazole. 
D. M. Livermore et al in 199644 from ICU patients at 35 centers were collected 
966 isolates of Consecutive klebsiellae. Isolates were sub-cultured on MacConkey agar to 
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confirm purity, and its identity was checked. Those confirmed as klebsiellae were stored 
at 20°C on nutrient agar slants. Out of 966 isolates, 716 were Klebsiella pneumoniae, 248 
were Klebsiella oxytoca and 2 were Klebsiella ozaenae. Production of extended-spectrum 
beta-lactamases (ESBLs) was derived in 220 isolates on the basis of synergy between 
ceftazidime and clavulanate. Putative ESBL producers received from 23 centers, 
including 20 of 27 that contributed more than 10 klebsiellae. Over 88% of putative ESBL 
producers were resistant to ceftriaxone 1 mg/L ceftazidime 2 mg/L, and aztreonam 1 
mg/L, whereas, amongst ESBL-negative isolates, more than 98% of the K. pneumoniae 
and 87% of the K. oxytoca were susceptible to the above concentrations. Putative ESBL 
producers were more resistant to cefuroxime and cefoxitin than non-producers, but not to 
biapenem. MIC distributions of piperacillin/tazobactam, aminoglycosides and 
ciprofloxacin were bimodal for ESBL producers, with some isolates highly sensitive and 
others were very resistant. 70% of putative ESBL producers were susceptible to 
piperacillin/tazobactam 16+ 4 mg/L, but 30% were resistant, some were highly so. 
Resistance to this combination, and to the ciprofloxacin, was clustered in certain centers. 
2 other groups of cephalosporin-resistant isolates were also identified besides ESBL 
producers, viz. (i) 20 K. oxytoca, from 15 centres and (ii) nine isolates, from three 
centers. Examination of the hospitals' own susceptibility data indicated up to 33% of 
putative ESBL producers had been reported susceptible to the third-generation 
cephalosporins or monobactams.  
Papapanou P.N. et al in 1997 compared the routine culture techniques of non-
selective and selective media in combination with routine biochemical testing using 
commercial test panels with "checkerboard" DNA-DNA hybridization methodology 
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using whole genomic digoxigenin labeled DNA probes for the analysis of the 
composition of subgingival microbiota. 70 subjects with a total of 283 subgingival plaque 
samples analyzed for Porphyrotnonas gingivalis. prevotella nigrescens,  prevotella 
intermedia, bacteroides forsythus,  fusobacterium nucleatum, campylobacter rectus, 
eikenella corrodens, actinobacillus actinotnycetemcomitans, streptococcus mutans and 
streptococcus sanguis. Checkerboard technology has resulted in higher prevalence figures 
for half of the species tested when compared to culture data. Also the checkerboard 
methodology has resulted in statistically significant higher bacterial counts for the 
majority of the species. 
M. Sakaguchi et al in 199721 did retrospective study on 91 patients with deep 
neck infections to determine the pattern of clinical disease and to formulate a 
management plan. The aim of the study was to identify the pattern of clinical condition 
and to formulate a management plan. Spaces involved were determined by clinical, 
radiologic, and by operative findings were peritonsillar (72), parapharengeal (8), 
submandibular (7), retropharengeal (1), superficial (1), anterior visceral space (1) and 
visceral vascular space (1). Gram's stain, anaerobic and aerobic cultures, were done on 
purulent material obtained by the aspiration with a syringe or by swabs. Results of 
cultures were only available for 29 of the 91 patients. 9 Of these, 25 cultures were 
positive and 4 were negative. 12 of the 25 specimens had more than 1 organism. Most 
common organisms isolated were streptococci viridans group, followed by Neisseria 
species and anaerobes accounted for 4/25 (16%) of the positive cultures. He concluded 
that the treatment of deep neck infections has three main aspects: medical management, 
surgical management, and airway control. 
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Franklin D. Lowy et al in 1998 described extensively about the staphylococcus 
aureus organisms and medical progress of staphylococcus aureus infections includes its 
components and products.  Pathogenesis of the disease, mechanisms of resistance to 
antimicrobial agents, treatment of staphylococcus aureus infection, prevention of the 
disease were described. Also described about the frequencies of both hospital and 
community acquired staphylococcus infections, the frequency of infection increases 
steadily and treatment became more difficult because of the emergence of multi drug 
resistant strains. 
Keith F. Barker in 199918conducted a review over antibiotics used in United 
Kingdom and the antibiotic resistance in British population. Author states that 
mechanism of resistance in bacteria is mainly due to (a) Enzymatic modification or 
destruction of the antibiotic; (b) Reduced antibiotic uptake into  the bacterium; (c) 
Increased efflux of antibiotic from the bacterium; (d) Alteration or production of a new 
target site; (e) Over-expression of the drug target site. Author concluded that the bacterial 
infection remains a public health problem worldwide over past 50 years with the 
development of antibiotic resistance. In recent years multi-resistant gram negative 
bacteria ‘superbugs’ has been reported and justified in their studies. Author also 
concluded that antibiotic resistance is a complex, continually evolving problem which is 
often difficult to put into perspective. Highly simplistic approaches to reduce the 
consumption and develop significant new agents are formidable tasks. 
Tomoari Kuriyama et al in 200050 conducted a study and the aim of the study 
was to determine the current status of beta-lactamase producing bacteria in orofacial 
odontogenic infections. Microbiologic data regarding the purulent exudates from 111 
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cases with orofacial odontogenic infections were analyzed in relation to past 
administration of beta -lactams. Beta-lactamase producing bacteria were isolated more 
frequently from the beta -lactam administered group (38.5%) than from the beta -lactam-
nonadministered group (10.9%; P < .005). The predominant bacteria isolated included 
Prevotella (the most frequent isolate), streptococci viridans, Fusobacterium, 
Peptostreptococcus, and 7.1% of total isolates produced beta-lactamase. Penicillin and 
cefazolin worked well with beta-lactamase–nonproducing Prevotella. Cefmetazole, 
sulbactam/cefoperazone, and imipenem worked well against both types of Prevotella. If 
the patient has not received beta-lactam antibiotics in course of infection, even if the 
patient has received β-lactam antibiotics with an appropriate dose for a deviation of l day 
or 2 days, the prescription of penicillin and first generation cephalosporins is suitable. If 
the patient already received antimicrobial therapy with β-lactams in the course of 
infection for duration of 3 days or more, in such cases beta lactamase-stable beta- lactam 
are recommended. 
Tomoari Kuriyama et al in 2000 conducted a study on 163 patients with 
orofacial odontogenic infection and concluded that Streptococci viridians, anaerobic 
gram–positive cocci and anaerobic gram-negative rods are isolated frequently from the 
orofacial infection. The susceptibility results suggest cefazolin may not have more 
advantages than penicillin, but cefmetazole may be more effective against infection than 
the penicillin. Cefmetazole were effective against all test pathogens. Erythromycin was 
ineffective against streptococcus viridans and most Fusobacterium. Clindamycin exerted 
a strong antimicrobial activity against anaerobes. Penicillin was effective against almost 
all the pathogens, although it did not work well against β-lactamase positive Prevotella. 
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Minocycline were effective against most of the test pathogens. The antimicrobial activity 
of levofloxacin against viridans streptococci was not strong. 
Kuriyama T.et al in 2001 conducted a study from 93 pus specimens of orofacial 
odontogenic infections. The incidence of beta lactamase production in anaerobic gram 
negative rods isolated and antibiotic susceptability of these isolates against 11 antibiotics 
were determined. 191 anaerobic gram negative rods were isolated, beta-lactamases was 
detected in 35.6% of the black pigmented prevotella and 31.9% of the non pigmented 
prevotella. Ampicillin, cefotaxim, and cefazolin showed decreased activity. Where as the 
activity of ampicillin/sulbactum, imipenem and cefmetazole continued to be effective 
against beta lactamase positive prevotella strains. All tested beta lactamase antibiotics 
where effective against Porphyramonas and Fusobacterium. Erythromycin showed 
decreased activity against nonpigmented Prevotella and Fusobacterium. Minocyclin, 
clindamycin and metronidazole were powerfull antibiotics against which anaerobic gram 
negative rods could be tested.  
William Storoe in 200111 performed a retrospective review, which compared two 
cohorts of the patient admitted in 1980 and in 1990. He found there is a marked 
difference in type and prevalence of bacteria isolated.  Gram positive cocci were 
frequently found in 1990s patient than from the 1980s patients. 1990s patients were more 
resistant to antibiotics compared to 1980s patients. There were no clinically significant 
differences between patient characteristics admitted during 1980 and 1990. Although 
there were differences in type and prevalence of bacteria isolated, it was mainly due to 
changes in nomenclature and identification protocols and isolation techniques. 
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Kuriyama T et al in 20022.  Described the beta-lactamase production and 
antimicrobial susceptibility of mainly anaerobic gram-negative rods were isolated from 
the pus specimens of 93 orofacial odontogenic infections and reported the bacteriology 
and antimicrobial susceptibility of the bacteria other than anaerobic gram-negative rods, 
mainly gram-positive cocci, Peptostreptococcus micros and Streptococcus constellatus 
were the frequent isolates. Eubacterium species, Corynebacterium species, and 
Peptostreptococcus prevotii, were recovered only from dentoalveolar infections, Gemella 
morbillorum were found more frequently in periodontitis than in other infections. Beta-
Lactamase-positive strains were detected only in staphylococci. Ampicillin, 
ampicillin/sulbactam, cefazolin, cefotaxime, imipenem, erythromycin, clindamycin and 
levofloxacin showed high susceptibility rates (77%) against viridans streptococci, 
Peptostreptococcus and Gemella. Minocycline showed a high MIC90 value against 
viridans streptococci (32 mg/ml), and metronidazole was effective against 
Peptostreptococcus and Gemella.  
Flynn TR et al in 200317, described about the antibiotic selection in the head and 
neck infections. He described about the molecular biology of the antibiotic resistance. 
The bacteria acquire antibiotic resistance by alteration of a drugs target site, inability of a 
drug to reach the target, inactivation of the antimicrobial agent, active elimination of the 
antibiotic from the cell. The bacteria acquire resistance genes by spontaneous mutation, 
gene transfer, bacteriophages, mosaic genes, and described about the various antibiotics. 
Saini. S. et al in 200316 conducted a study and compared the normal aerobic and 
anaerobic oral flora with flora from the deep seated dental caries, gingivitis, and 
periodontitis. All 100 cases include 25 control groups yielded microbes. 97% of orodental 
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infections are polymicrobial, and three or more microbes were found in 84% of the cases. 
Streptococcus mutans and anaerobic lactobacilli were common in the dental caries; 
Actinomyces and Peptostreptococcus species, were found in gingivitis. Actinobacillus 
actinomycetemcomitans and porphyromonas gingivalis were found in periodontitis.  
D.K Dhariwal et al in 2003 reported a rare and potentially fatal complication of 
epidural spinal abscess following a dental extraction, the causative organism was 
Streptococcus milleri for which Cefotaxime and flucloxacillin were given intravenously. 
Richard H. Haug in 2003 reported about the changing microbiology of 
maxillofacial infections. The changes in the microbiology of infections of odontogenic 
etiology rest in changes in nomenclature and ability to isolate the organisms. The changes 
in the microbiology of infections associated with maxillofacial trauma are not caused by 
the injuries but are related to the nosocomial systemic infection and emergence of the 
resistant microorganisms. The changes in the microbiology of nasal and paranasal sinus 
infections are associated with the emergence or reemergence of strains of bacteria that are 
resistant to the common antibiotics. 
Stefanopoulos P. K. et al in 200445 reviewed the literature on orofacial 
odontogenic infections, and indicates that the underlying microflora is polymicrobial, 
predominantly involving strictly anaerobic gram-positive cocci and gram-negative rods, 
along with facultative and microaerophilic streptococci. Superoxide dismutase produced 
by moderate anaerobes renders them by definition tolerant of oxygen levels of 2% to 8% 
and is considered a prerequisite to their pathogenicity. Antibiotic resistance is an 
important consideration in managing the orofacial odontogenic infections. Reported that 
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the Beta-lactamase activity among gram-negative anaerobic rods aer responsible for 
clinical failures with penicillin treatment. Although penicillin remains the antibiotic of 
choice for mild to moderate odontogenic infections in the immunocompetent host but 
pencillin should not be used as initial therapy for more serious infections possibly 
involving penicillin resistant oral anaerobes. However, in more severe cases where there 
is a narrow margin of acceptance of possible therapy failure, it is recommended to 
manage with adequate anaerobic spectrum such as clindamycin or combinations of an 
aminopenicillin with beta-lactamase inhibitor; broader antimicrobial coverage is 
indicated for patients with impaired host defenses.  
J. Wang, et al in 2005 conducted a five-year retrospective study of odontogenic 
maxillofacial infections in a large urban public hospital. Out of 250 cases 157 cases of 
infection was odontogenic in origin. Only eight of the 157 patients were prescribed 
intravenous penicillin alone. 94 received penicillin plus metronidazole, while 31 were 
given clindamycin therapy, 14 a cephalosporin, and 10 a combination of antibiotics, 
usually gentamicin, ampicillin and metronidazole, this being reserved for the most severe 
infections. Authors identified potential risk factors and suggested that early dental 
extraction, incision and drainage, coupled with intravenous antibiotic therapy, is the most 
effective treatment. Antibiotic therapy can be empirical. Obtaining of cultures and 
sensitivity reports does not appear to be clinically helpful, and did not lead directly to any 
antibiotic or other treatment changes.  
Boyanova L. et al in 2006 conducted a study and evaluated the incidence and 
susceptibility to antibacterial agents of anaerobic strains in 118 patients with head and 
neck abscesses (31) and cellulitis (87). Odontogenic infections were the most common 
Review of Literature 
 
  24 
 
source in 73 of (77.7%) of 94 patients. Anaerobes in patients with odontogenic and other 
sources of infection were 82.2 and 71.4%. Total of 174 anaerobic strains were found. The 
predominant bacteria were Prevotella (49 strains), Fuso bacterium species (22), 
Actinomyces spp. (21), Anaerobic cocci (20) and Eubacteriurn spp. (18). Bacteroides 
fragilis strains isolated from 7 (5.9%), specimen. The resistance rate to amoxicillin of 
Gram-negative anaerobes was 26.9% (21 of 78 strains). Resistance rates to clindamycin 
and metronidazole of Gram-negative anaerobes were 5.4% (4 of 74) and 2.5% (2 of 79), 
respectively, and those of Gram-positive species were 4.5% (3 of 66) and 58.3% (42 of 
72), respectively. Only one strain was not susceptible to ampicillin/sulbactam. 
Thomas R. Flynn et al in 200622 evaluated 37 consecutive hospitalized patients 
with odontogenic infection were treated with intravenous penicillin and prompt incision 
and drainage. Seventeen (19%) of the 90 isolated strains were penicillin resistant; one or 
more penicillin resistant organisms were found in 13 (54%) of the 24 cases with 
antibiotic sensitivity data. 4 clindamycin-resistant strains were identified, one each of 
Streptococcus milleri, Eikenella corrodens, and Streptococcus mitis, and one strain of 
Klebsiella pneumonia that was also resistant to penicillin. Clindamycin-resistant strains 
were identified in 4 (17%) cases with sensitivity data. Author concluded that penicillin 
resistance, resulting in penicillin therapeutic failure, was unacceptably high in this 
sample. Alternative antibiotics, such as clindamycin, should be considered in hospitalized 
patients with odontogenic infection. 
Thomas R. Flynn et al In 2006 conducted a study on thirty seven consecutive 
patients and identified the significant predictors of four outcomes in patients with severe 
odontogenic infections: penicillin therapeutic failure (PTF), abscess formation, need for 
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reoperation and length of hospital stay (LOS). Found that culture of Peptostreptococci 
was a negative predictor of abscess formation. There was no significant predictor of PTF 
or reoperation on multivariate analysis, although Pencillin-resistant organisms were 
isolated in all cases of PTF. Author concluded that the increased LOS in severe 
odontogenic infections is predicted by the anatomic extent and severity of the infection 
and the occurrence of complications such as PTF and the need for reoperation. PTF is 
significantly associated with later identification of PCN-resistant organisms. 
Rege A.J. et al in 200610 conducted a six year retrospective study on 103 
patients. The submandibular space was most frequent for single space abscesses (30%) 
followed by buccal space (27.5%) and lateral pharyngeal space (12.5%).   The most 
common bacteria isolated were streptococci, Prevotella, Staphylococci & 
Peptostreptococcus. Streptococci viridans demonstrated an 87.1% sensitivity rate to 
penicillin. Streptococci Viridans also exhibited high susceptibility to ampicillin (98.4%), 
clindamycin (86.3%), ciprofloxacin (100%), levofloxacin (98.6%) cefazolin (100%), 
erythromycin (83.4%), and vancomycin (100%). Staphylococci showed a 27.3% 
susceptibility rate to penicillin and sensitivity to ampicillin (41.2%), cefazolin (70.0%), 
ciprofloxacin (95%), clindamycin (89.5%), erythromycin (75%), levofloxacin (84.2%), 
and vancomycin (100%). 
Osborn T. M. et al in 2008 described about the anatomy of the fascial layers, 
deep neck spaces, microbiology of the deep neck spaces which includes the most 
common organism associated with deep neck infections was Staphylococcus aureus. 
Drug resistance has, however, contributed to a change in the microbial flora associated 
with these serious infections, which are now most commonly associated with aerobic 
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streptococcal species and nonstreptococcal anaerobes. Commonly cultured organisms 
include Streptococcus viridans, Streptococcus milleri group species, B-hemolytic 
streptococci, Neisseria species, Peptostreptococcus, coagulase-negative staphylococci 
and Bacteroides. Anaerobic bacteria include Prevotella and Porphyromonas species, 
Actinomyces species, Bacteroides species, Propionobacterium, Hemophilus, and 
Eikenella. Anaerobic bacteria are found in more than half of severe odontogenic 
infections.  
Munish Kohli et al in 200947 identified the most common micro-organisms 
causing odontogenic infections and their antimicrobial susceptibility.  from 80 patients 
pus samples were collected aseptically by aspirating the abscess using sterile 18/22 gauge 
needle with a 2ml syringe, the specimen was immediately inoculated in sterile Robertson 
cooked meat broth (RCM)  for transportation of anaerobic organisms. They were cultured 
(aerobically and anaerobically) and stained for morphological study of the isolates. A 
total of 109 micro-organisms were isolated. In 28(35%) of cases pure aerobes were 
identified, pure anaerobes in 18(22.5%) cases, mixed aerobes and anaerobes in 
10(12.5%) of cases, mixed aerobes in 15(18.75%) and mixed anaerobes were identified 
in 6(7.5%) cases. Ofloxacin was the most sensitive drug followed by ciprofloxacin and 
sparfloxacin for pure gram positive organisms. The most resistant drugs were amoxicillin 
and ampicillin. The gram negative colonies were sensitive to cefotaxime. 
D. Robertson et al in 20091 published the microbiology of acute dental abscess 
and found that it is polymicrobial in nature and comprising facultative anaerobes, such as 
viridans group streptococci and the Streptococcus anginosus group, with predominately 
anaerobic cocci such as Prevotella and Fusobacterium species. Other causative 
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organisms found were Bulleidia extructa, Cryptobacterium curtum and Mogibacterium 
timidum. 
Paolo Boscolo-Rizzo et al in 2009 conducted a retrospective study of clinical 
characteristics and the management of submandibular space infections and to identify the 
predisposing factors of life-threatening complications. Author concluded that airway 
obstruction and spread of the infection to mediastinum are the most troublesome 
complications of submandibular space infections. Patients with cellulitis and small 
abscesses can respond to antibiotics alone. Surgical drainage should be performed in 
patients with large abscesses, Ludwig’s angina, anterior visceral space involvement, and 
in those who do not respond to antibiotic treatment. Early surgical drainage should 
always be considered even in seemingly less critical cases. 
Fábio Ricardo Loureiro Sato et al in 2009 conducted a retrospective study in 
210 patients. The main origin of infection was odontogenic (79.31%); The main facial 
spaces affected were the buccal mandibular space (50.00%), submandibular space 
(31.90%), and buccal maxillary space (19.05%). Surgical drainage were carried out in 
46.67% of cases, and 10.95% of these interventions were performed under general 
anesthetic. Author concluded that no predisposition concerning gender or race was 
detected. The therapeutic protocol adopted presented very positive results, with a small 
number of complications. 
Opeyemi O et al in 200923 reviewed their experiences with deep neck abscesses 
and identified the unique trends in their patient population with 106 Case series and chart 
review of patients with deep neck space abscesses, odontogenic infections were the most 
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common cause of deep neck abscesses (49.1%). Among the 52 odontogenic cases, 
Streptococcus spp were the most common pathogens (44.4%). Second or third generation 
cephalosporins such as cefoxitin or ceftriaxone were effective. Alternatively, a penicillin 
and beta-lactamase inhibitor combinations such as ampicillin-sulbactam also provides 
adequate coverage.  Clindamycin used as an alternative and is preferred in those allergic 
to penicillin. Suspicion or confirmation of methicillin-resistant Staphyloccocus aureus 
warrants the use of effective antibiotics such as vancomycin, rifampin, or 
sulfamethoxazole-trimethoprim.  
Mrudula Patel et al in 2009 conducted a study and compared the clinical, 
microbiological, enzymatic, and host immune response variables between 15 patients 
with Ludwig’s angina and 42 patients without Ludwig’s angina. Most Common 
organisms found are Staphylococcus aureus and black-pigmented bacteroides from 
patients with Ludwig’s angina. Author concluded that the elevated levels of CRP and 
urea could indicate the severity of infection in patients with Ludwig angina.  
Laith Hussein Al-Qamachi et al in 201030 stated that primary treatment for deep 
neck spaces odontogenic infection (DNSOI) with suppuration is surgery and systemic 
antimicrobial therapy. Initial antimicrobial therapy is empirical. Over the last decade, 
there is a change in practice with 2nd generation cephalosporins and metronidazole, 
replacing benzylpencillin and metronidazole. Recently, evidence has emerged suggesting 
that the antimicrobial resistance in nosocomial infections could be related to the 
widespread use of second and third-generation cephalosporins. A total of 75 cases were 
retrospectively identified, Streptococcus milleri and mixed anaerobes were predominant. 
Only in 3 cases (4%) were found to be penicillin-resistant. The substitution of 
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benzylpenicillin for cefuroxime as an initial empiric therapy for DNSOI has been equally 
efficacious in the large majority of cases.  
Dipesh D. Rao et al 2010 performed a 4-year prospective study on maxillofacial 
space infections of odontogenic origin in diabetic patients compared with nondiabetic 
patients. Result showed that a total of 111 patients were identified out of which 31 were 
diabetic. The submandibular space being the most common space involved in both the 
group and organisms commonly isolated were Streptococcus species s. The empirical 
antibiotic used were amoxicillin plus clavulanic acid combined with metrogyl in 70.27% 
cases. Author concluded that Streptococcus species is still the most common causative 
pathogen irrespective of the diabetic status of the patient. The same empirical antibiotic 
therapy of amoxicillin plus clavulanic acid combined with metrogyl along with 
hyperglycemia control and surgical drainage of infection yielded satisfactory resolution 
of infection in the diabetic patients as well. 
Paul. W. Poeschl et al in 201048 conducted a retrospective study and identified 
the major pathogens responsible for deep space head and neck infections and their current 
resistance to routinely used antibiotics. A total of 206 patients suffering from 
odontogenic deep space infections treated by means of surgical intervention and 
intravenous administration of antibiotics. The results showed that the predominant 
bacteria were Streptococci viridans, Staphylococci, Peptostreptococcus, Prevotella, and 
Bacteroides. The aerobes were resistant against clindamycin in 18%, macrolides in 14%, 
and penicillin G in 7%. The anaerobes were resistant to clindamycin in 11%, to 
metronidazole in 6%, and to penicillin G in 8%. Author concluded that the high 
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resistance rate for clindamycin and macrolides was especially striking and may 
necessitate an adaptation of our antibiotic regime in the future. 
Marilyn E. Levi et al in 201115 Reviewed the serious nature and potential 
dangers that exists from odontogenic infections and the antibiotics available to treat these 
infections. Successful treatment requires an understanding of the microflora, the regional 
anatomy, and the disease process. In the oral cavity, more than 80% of the cultured 
bacteria include streptococci, Peptostreptococcus, Veillonella, Lactobacillus, 
Actinomyces and Corynebacterium.  
Thomas R. Flynn in 201139 this article is an attempt to answer the questions with 
a systematic review of the currently available scientific literature on this multifaceted 
topic. The results of this systematic review may allow oral and maxillofacial surgeons 
(OMS) to have less concern over the choice of antibiotic prescription in the management 
of odontogenic infections. Among the antibiotics commonly used for odontogenic 
infections (OI), it seems that no one antibiotic is clearly superior to all others. Antibiotics 
may therefore be chosen according to cost and safety, with individualized consideration 
of the patient’s medical history. Surgical treatment, consisting of incision and drainage 
and removal of the odontogenic cause by extraction, endodontic therapy, or other means, 
is of primary importance. 
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The study was conducted in total of 142 patients having orofacial space infections 
attending the Out Patient Department of Oral & Maxillofacial surgery in Sree 
Mookambika Institute of Dental Science, Kulasekharam from September 2010 to 
September 2012. Pus samples and aspirates were collected aseptically from the patients 
for aerobic and anaerobic microbiological study. Proper medical/dental history, clinical 
signs and symptoms were recorded and relevant investigations were done. 
SAMPLE SIZE 
 Minimum of 142 patients with head and neck fascial space infections of 
odontogenic origin are taken up for the study. This includes males and females with an 
age group of 5 years to 73 years. 
SELECTION CRITERIA 
Inclusion Criteria 
 Patients with head and neck fascial space infections of odontogenic origin. 
 Patient who had not taken antibiotics for the head and neck fascial space 
infections of odontogenic origin. 
Exclusion Criteria 
 Patient taken antibiotics at randomly for head and neck fascial space infections of 
odontogenic origin. 
 Patient not willing to participate in the study. 
 Patients with head and neck fascial space infections other than odontogenic 
origin. 
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 Patients with culture and sensitivity results show no growth.   
ARMAMENTARIUM  
1. Local anesthetic lignocaine with adrenalin (LIGNOX 2% A, INDICO 
REMEDIES LTD. Mumbai, India)  
2. Sterile 24 gauge and 25mm length needle with 3 ml syringe (Dispo Van, 
Hindustan Syringes & Medical Devices LTD. India) 
3. Sterile 18 gauge and 38mm length needle with 5 ml syringe (Dispo Van, 
Hindustan Syringes & Medical Devices LTD. India) 
4. Bard Parker blade number-11 (GLASSVAN sterile surgical blades, Niraj 
Industries Pvt. Ltd, Faridabad, India.) 
5. Bard Parker Handle (Sirag surgical Enterprises, Chennai, India ) 
6. Transport cotton swab stick (Labtech medico Pvt. Ltd. Kerala, India )  
7. Brain heart infusion broth (HIMEDIA Laboratories Pvt. Ltd. Mumbai India.) 
8. Chocolate agar plate (HIMEDIA Laboratories Pvt. Ltd. Mumbai India.) 
9. Maconkey’s agar plate (HIMEDIA Laboratories Pvt. Ltd. Mumbai India.) 
10. Nutrient Agar plate (HIMEDIA Laboratories Pvt. Ltd. Mumbai India.)  
11. Blood agar plate (HIMEDIA Laboratories Pvt. Ltd. Mumbai India.) 
12. Mueller Hinton Agar plate (HIMEDIA Laboratories Pvt. Ltd. Mumbai India.) 
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13. Antimicrobial disc. (Labtech medico Pvt. Ltd. Kerala, India ) 
14. Anaerobic jar (HIMEDIA Laboratories Pvt. Ltd. Mumbai India.) 
15. Anaerogas pack with indicator tablet (HIMEDIA Laboratories Pvt. Ltd. 
Mumbai India.) 
ANTIBIOTICS USED FOR THE STUDY 
S. No Antimicrobial Class Representative Antibiotics 
1. Sulfonamides Sulfadiazine 
2. Fluoroquinolones  
Ofloxacin, Norfloxacin   Gatifloxacin,     Levofloxacin,  
Nalidixic acid,  Ciprofloxacin, Cotrimoxazole 
3. Aminoglycoside Gentamycin,  Amikacin, Neomycin, Streptomycin 
4. Macrolides Erythromycin,  Azithromycin , Roxithromycin 
6. Penicillin’s  
Ampicillin,   Amoxicillin, Penicillin G, Amoxicillin and 
clavulanic acid,  Piperacillin,  Cloxacillin,  Meropenem 
7. Cephalosporin 
Cefotaxime,   Cefixime,       Cefuroxime,   Cefpodoxime   
Cephalexin,    Ceftazidime,        Cefazolin 
8. 
Broad Spectrum 
Antibiotics 
Doxycycline, Tetracycline, Chloramphenicol 
9. 
Miscellaneous 
antibiotics  
Linezolid,       Clindamycin     Bacitracin,      Vancomycin,     
Furoxone,       Nitrofurantoin,       Septran,          Sporidex 
 
PROCEDURE FOR AEROBIC CULTURE 
STEP 1 -SAMPLE COLLECTION 
 After wearing sterilized gloves, site was anesthetized by local anesthetic (2% 
lignocaine with adrenalin) depending on the condition, the pus sample either 
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collected intra orally or extra orally. Pus sample were collected by transport 
cotton swab stick directly from the site and it was sent immediately for aerobic 
culture.  
STEP 2 - SPECIMEN INOCULATION AND CULTURE 
 Clinical material was transported immediately to the lab. The pus sample from the 
transport cotton swab stick is inoculated into the media plates by using a flame 
sterile straight wire loop to streak the inoculum into the media and spread the 
inoculum in a zig-zag pattern.  
 The culture was done in the following medium. 
1. Nutrient agar medium 
2. Blood agar medium 
3. MacConkey agar medium 
NUTRIENT AGAR 
Composition 
Ingredients                                                      Gms / Litre 
Peptic digest of animal tissue  -  5.000 
Sodium chloride   -  5.000 
Beef extract    -  1.500 
Yeast extract    -  1.500 
Agar     -  15.000 
Final pH (at 25°C) 7.4±0.2 
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Preparation- Add 28g of nutrient agar in 1000ml of distilled water. The mixture is then 
heat to boiling till the medium dissolve completely. Then the medium is sterilized by 
Autoclaving at 15 lbs pressure (121°C) for 20 minutes. Allow this solution to cool to ~ 
50°C.  It should be keep a close watch over the solution as it cools; if leave it too long, it 
will solidify in the jar and will be of no use.  Do not pour the solution when it is too hot 
as it may damage the petri dishes. Pour solution into petri dishes and allow it to cool to 
room temperature to set.  In most cases, the pouring of the agar should be done in the 
laminar flow hood to maintain sterile conditions. The Plates can be stored in the fridge 
for up to 4 weeks for use. 
BLOOD AGAR 
Composition  
1. Peptose Peptone  - 15.00 gm/litre  
2. Liver extract   - 2.50 gm/litter 
3. Yeast extract   - 5.00 gm/litre 
4. Sodium chloride  - 5.00 gm/litre 
5. Bacteriological Agar  - 15.00 gm/litre 
Final pH (at 250 C) 7.4+ 2 
 
Preparation: Suspended 21.25 grams of the medium in 500ml of distilled water and 
mixed well. It was heated with frequent agitation and boiled for 1 minute until the 
medium was completely dissolved. It was then distributed in appropriate containers. The 
medium was sterilized at 15 lbs pressure (121°C) for 15 minutes. Allow it to cool to 
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45°C-500C and aseptically added 7% sterile defibrinated sheep blood. Mixed well and 
poured into Petri dishes. 
 It is an enriched media, which is prepared by adding sheep blood (5-10%) to the 
sterilized melted nutrient agar at 45°C. It consist of nutrient agar 90 ml and sterile sheep 
blood 10 ml. it is one of the best laboratory media since most of the organisms grow well 
on it. 
MACCONKEY AGAR 
Composition 
1. Peptic digest of animal tissue  - 17.00 gm/litre 
2. Proteose peptone    - 3.00 gm/litre 
3. Lactose     - 10.00 gm/litre 
4. Bile salts     - 1.5 gm/litre 
5. Sodium chloride    - 5.00 gm/litre 
6. Neutral red    - 0.03 gm/litre 
7. Agar    - 15.00 gm/litre 
Final pH (at 250 C) to 7.1+0.2 
Preparation: Suspend 51.53 gm of powder in 1 liter distilled water. Mix well dissolves it 
by heating with frequent agitation. Boil for 1 minute until complete dissolution. Sterilize 
in autoclave at 121°C for 15 minutes cool to 45°C mix well and dispense into plates. 
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Allow the plates to solidify and place them upside down to avoid excess moisture on the 
surface of the medium. Prepared medium should be stored at 8-15°C. Colour is violet red. 
It is a culture medium designed to grow Gram-negative bacteria and stain them for 
lactose fermentation. The lactose fermenters form the pink colonies while non lactose 
fermenters produce colorless or pale colonies. 
 Then these inoculated culture media plates were immediately incubated at 37o C 
for 24 to 48 hours in an aerobic atmosphere, after 24 to 48 hours the plates are 
ready for the observation of colonies and further gram staining, biochemical and 
antibiogram tests. 
GRAM STAINING 
The gram staining reaction is used to identify the pathogens in specimens and 
cultures by their Gram reaction and morphology. Gram positive bacteria stain dark purple 
with crystal violet or methyl violet and are not decolorized by acetone or ethanol. Gram 
negative bacteria stain red because after being stained with crystal violet or methyl violet 
they are decolorized by acetone or ethanol and take up the red counter stain such as 
neutral red, safranin or dilute carbol fuchsin. 
STEP 3- BIOCHEMICAL TESTS FOR IDENTIFICATION OF MICROBES 
 After material is dispended to culture media and incubated for 24 to 48 hours will 
visualize colonies of grown organism. Then all sets of plates will apply following 
biochemical tests to identify the genus and species of bacteria they are as 
follows:- 
1. Methyl red test 
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2. Voges-Pros Kauer test 
3. Oxidation fermentation test 
4. Indole test 
5. Triple Sugar Ion test 
6. Uriase test 
7. Citrate test 
8. Manitol test  
9. Motility test 
After 24 hrs we will inspect the following test and diagnosis of infection is made. 
METHYL RED TEST 
 This test is employed to detect the production of acid during the fermentation of 
glucose and maintenance of a pH below 4.5 in an old culture. Five drops of 0.04% 
solution of methyl red are added to the culture in glucose phosphate medium which had 
been incubated at 30 degree centigrade for five days, mixed well and a red colour is 
positive while yellow signifies negative test. 
VOGES-PROS KAUER TEST 
 This test depends on the production of acetyl methylcarbinol from pyruvic acid, 
as an intermediate stage in its conversion to 2:3 butylene glycol. In the presence of alkali 
and atmospheric oxygen, the small amount of acetyl methylcarbinol present in the 
medium is oxidized to diacetyl which reacts with the peptone of the broth to give red 
colour. First alpha-napthol (also called Barritt’s reagent A) and then potassium hydroxide 
(also called Barritt’s reagent B) are added to the tube. The culture should be allowed to 
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sit for about 15 minutes for color development to occur. If acetoin was produced then the 
culture turns a red color (positive result); if acetoin was not produced then the culture 
appears yellowish to copper in color (a negative result). 
OXIDATION FERMENTATION TEST 
 To perform this test simply swab some of your test culture into one of the boxes 
on an oxidase dry slide. If a color change to purple or blue is evident at 30 seconds to 1 
minute, then the result is positive. It is important that the test is read by one minute to 
ensure accurate results. This laboratory test is based on detecting the production of the 
enzyme cytochrome oxidase by Gram-negative bacteria. It is a hallmark test for the 
Neiserria. It is also used to discriminate between aerobic Gram-negative organisms like 
Pseudomonas aeruginosa and other Enterobacteriacia. 
INDOLE TEST 
            Testing for indole production is important in the identification of enterobacteria, 
most strains of E.coli, P.vulgaris, P.rettgeri, M.morganii, and providencia species break 
down the amino acid tryptophan with the release of indole. Red surface layer shows 
positive indole test and negative indole test shows no red surface layer. 
URIASE TEST 
 This test is used to detect the enzyme urease, which breaks down urea into 
ammonia. Ammonia is a base and thus will raise the pH of the media if it is present. This 
change in pH is indicated by a pH indicator called phenol red which is present in the 
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media. A color change from yellow to bright pinkish-red is positive; lack of color change 
is a negative result.  
CITRATE TEST 
 Citrate test is used test the ability of bacteria to convert citrate (an intermediate of 
the Kreb’s cycle) into oxaloacetate (another intermediate of the Kreb’s cycle). In this 
media, citrate is the only carbon source available to the bacteria. If it cannot use citrate 
then it will not grow. If it can use citrate, then the bacteria will grow and the media will 
turn a bright blue as a result of an increase in the pH of the media.  
MOTILITY TEST 
 The motility test is not a biochemical test since we are not looking at metabolic 
properties of the bacteria. Rather, this test can be used to check for the ability of bacteria 
to migrate away from a line of inoculation. To perform this test, the bacterial sample is 
inoculated into motility media using a needle. Simply stab the media in as straight a line 
as possible and withdraw the needle very carefully to avoid destroying the straight line. 
After incubating the sample for 24-48 hours observations can be made. Check to see if 
the bacteria have migrated away from the original line of inoculation. If migration away 
from the line of inoculation is evident then you can conclude that the test organism is 
motile (positive test). Lack of migration away from the line of inoculation indicates a 
lack of motility (negative test result). 
COAGULASE TEST  
This test is used to identify Staphylococcus aureus which produces the enzyme 
coagulase, it causes plasma to clot by converting fibrinogen to fibrin. Two types of 
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coagulase are produced by most strains of S.aureus, free coagulase and bound coagulase. 
Free coagulase converts fibrinogen to fibrin by activating a coagulase reacting factor 
present in plasma. Free coagulase is detected by clotting in the tube test. Bound coagulase 
converts fibrinogen directly to fibrin without requiring a coagulase factor. It can be 
detected by the clumping of bacterial cells in the rapid slide test. A tube test must always 
be performed when the result of a slide test is not clear, or when the slide test is negative 
and Staphylococcus has been isolated from a serious infection. 
STEP 4 - ANTIBIOTIC SENSITIVITY TEST 
 After various test mentioned above will identify the genus and species of bacteria. 
Then the grown colonies of organism are spread over the Mueller Hinton Agar 
media plate. Labelled antibiotic discs are placed over the grown colonies of 
organism on the Mueller Hinton Agar media plate by the help of sterilized 
forceps. This plate will be again incubated for 12 hours to 24 hours at 37oC. A 
zone of inhibition is appeared surrounding the antibiotic disc indicates the 
sensitivity of the organism to the particular antibiotic and the zone of inhibition is  
measured by the help of WHO quality control Chart to access the sensitivity of 
above mentioned discs. 
FOLLOW UP 
Clinical sign and symptoms were recorded frequently to assess the dissolution of 
infection. 
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PROCEDURE FOR ANAEROBIC CULTURE 
STEP 1- SAMPLE COLLECTION 
 After wearing sterilized gloves, site is anesthetized with depending on the 
condition of pus sample either collected intraorally or extra orally. The pus 
samples were collected by sterile 18 gauge and 38mm length needle with 5 ml 
syringe. After aspiration any free air was discharged and needle was capped 
immediately and material was dispensed in following transport medium. The 
transport medium used in the study was 1.5ml brain heart infusion broth which 
was sealed in a glass jar to maintain the anaerobic (condition) atmosphere in the 
tube for the survival of the anaerobic bacteria.  
STEP 2 - TRANSPORTATION OF COLLECTED SAMPLE 
 The commonly used transport media for storing the sample in viable condition 
from the site of collection of sample to the laboratory are: 
 PBS – Phosphate buffered saline 
 RS – Ringers Solution 
 BHI – Brain Heart infusion Broth 
 For the present study BHI was used as the transport media. 
 The clinical sample is then transported to the laboratory immediately for 
anaerobic culture. 
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BRAIN HEART INFUSION BROTH 
Composition  
1. Proteose Peptone Mixture  - 10.00 gm/litre 
2. Disodium Phosphate   - 2.50 gm/litre 
3. Beef Heart Infusion   - 10.00 gm/litre 
4. Sodium Chloride   - 5.00 gm/litre 
5. Calf Brain Infusion   - 7.50 gm/litre 
6. Beef Heart Infusion   - 10.00 gm/litre 
7. Dextrose    - 2.00 gm/litter 
Preparation: Suspended 37 grams of the medium in 1000 ml of distilled water, and it is 
mixed well until complete dissolution of the medium occurs. The medium was sterilized 
in autoclave at 15 lbs pressure (121ºC) for 15 minutes. The prepared medium should be 
stored at 8 to15°C. The color of the preparation is clear amber and slightly opalescent. 
The nutritionally rich base of Beef heart and Calf brain infusions and Peptone mixture 
provides nitrogen, vitamins, minerals and amino acids that support the growth of a 
variety of microorganisms.  Disodium phosphate acts as a buffer. Dextrose is the 
fermentable carbohydrate providing carbon and energy. Sodium chloride maintains the 
osmotic balance.  
STEP 3- ANAEROBIC INCUBATION 
 The sample is kept in the incubator without disturbing the anaerobic atmosphere 
for 24 hours.  Turbidity is observed after 24 hours confirming the growth of the 
organism. 
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STEP 4 - SPECIMEN CULTURE 
 Meanwhile the following media plates are prepared and kept for sterility check 
for 24 hours. 
(i) Nutrient agar 
(ii) Blood agar supplemented with hemin and vitamin 
(iii) MacConkey agar 
(iv) TSBV agar 
NUTRIENT AGAR 
Composition 
Ingredients                                                     Gms / Litre 
Peptic digest of animal tissue                                   5.000 
Sodium chloride                                                        5.000 
Beef extract                                                               1.500 
Yeast extract                                                             1.500 
Agar                                                                         15.000 
Final pH (at 25°C) 7.4±0.2 
Preparation- Add 28g of nutrient agar in 1000ml of distilled water. The mixture is then 
heat to boiling till the medium dissolve completely. Then the medium is sterilized by 
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Autoclaving at 15 lbs pressure (121°C) for 20 minutes. Allow this solution to cool to ~ 
50°C.  If leave it too long, it will solidify in the jar and will be of no use.  Do not pour the 
solution when it is too hot as it may damage the petri dishes. Pour solution into petri 
dishes and allow it to cool to room temperature to set.  Plates can be stored in the fridge 
for up to 4 weeks for use. 
BLOOD AGAR SUPPLEMENTED WITH HEMIN AND VITAMIN 
Composition 
Per Liter Purified Water 
Pancreatic Digest of Casein   - 10.0 g 
Peptic Digest of Animal Tissue  - 10.0 g 
Yeast Extract     - 2.0 g 
Glucose     - 1.0 g 
Sodium Chloride     - 5.0 g 
Sodium Bisulfite     - 0.1 g 
Hemin      - 0.005 g 
Vitamin K1     - 0.01 g 
Agar      - 15.0 g 
Sheep Blood, defibrinated    - 5% 
Materials & Methods 
 
  46 
 
TRYPTIC SOY-SERUM IN BACITRACIN VANCOMYCIN AGAR (TSBV) 
 TSBV is an enriched selective media for the isolation and presumptive 
identification of A.actinomycetemcomitans. 
 TSVB contains Bacitracin and Vancomycin at a concentration that inhibits most 
gram-positive and gram negative anaerobes, except for 
A.actinomycetemcomitans. 
 Storage: at room temperature in original container until use. Overheating and 
freezing is avoided. 
 Shelf Life: 90 days from date of manufacture. 
Composition 
Tryptic Soy Agar    - 40.0 g 
Yeast Extract     - 1.0 g 
Bacitracin     - 75.0 mg 
Vancomycin     - 5.0 mg 
Horse Serum     - 100.0 ml 
Distilled Water    - 1000.0 ml  
Final pH 7.1 +/- 0.2 at 25 degrees C. 
Materials & Methods 
 
  47 
 
 After sterility check, the incubated clinical sample is streaked on to the prepared 
sterile media plates.  Quadrant streaking is most preferred streaking method. 
 The plates are then sealed with paraffin tape (adhesive tape) such that no air 
enters the plates. 
 Anaerobic jar with gas pack and indicator tablets are kept ready. 
STEP 5- ANAEROBIC INCUBATION 
 The plates are immediately placed in the anaerobic jar packed tightly by the screw 
on top of the lid. Then the anaerobic jar is sealed using the paraffin tape. 
 The anaerobic jar is then kept in the incubator, which is kept under 370 C for 5-7 
days; undisturbed. 
ANAEROBIC INCUBATOR 
 Incubation of the streaked media plates is to be done under anaerobic 
conditions. 
 For this purpose, anaerobic jar is used.  It is a plastic transparent jar with a lid 
with a rubber tube for maintaining tight anaerobic condition. 
 The jar is packed tight with the lid that is tightened with the help of a screw on 
the top of the lid. 
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 The anaerobic condition is maintained inside the jar by placing a Gas pack in it. 
Gas pack has two components, CO2 releaser and a small porous pack called the 
O2 absorber. 
 An indicator tablet is placed inside the jar.  The tablet is usually pink in colour 
but when exposed to anaerobic atmosphere, it turns blue in colour.  When 
placed in the anaerobic jar and the sealed, the anaerobic condition is indicated 
by colour change of the indicator tablet to pink. 
 Thus the anaerobic jar along with gas pack and indicator tablet forms the 
complete anaerobic atmosphere for the incubation of the clinical sample 
streaked on media plates. 
STEP 6- IDENTIFICATION OF MICROBES 
 After the usual incubation period of 5-7 days, the plates are taken out of the 
anaerobic jar. The plates are now ready for the observation of colonies and further 
biochemical and antibiogram tests. Results obtained are recorded and the isolated 
colonies are sub cultured for further reference. 
BIOCHEMICAL TESTS  
 For the characterization of the isolated colonies, biochemical tests are 
performed: 
 Indole Test 
 Citrate Test 
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 Urease Test 
 Nitrate Test 
 Triple Sugar Iron Test 
 Results for the above biochemical tests were observed and recorded for 
characterization of isolated colonies.  
STEP 7- ANTIBIOTIC SENSITIVITY TEST 
 After various test mentioned above we will take Mueller Hinton Agar, and the 
colonies of bacteria are spread over this medium. Discs are placed which are mentioned 
above by the help of sterilized forceps. This plate will be again incubated for 12 hours to 
24 hours at 37oC. Zone of Inhibition is measured by the help of WHO quality control 
Chart to access the sensitivity of above mentioned discs. 
FOLLOW UP 
Clinical signs and symptoms were recorded frequently to assess the dissolution of 
infection. 
 
Results 
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STATISTICAL ANALYSIS 
The data was analyzed by student t test and Chi square test for statistical 
significance within group and between groups. For the analysis SPSS (16.0 version) was 
used. All the data has been represented as frequencies and proportions. The data was 
evaluated using chi square test. P<0.05 is considered as statistically significant.  
TABLE-1: DISTRIBUTION OF   ODONTOGENIC INFECTION  
In this study out of 142 patients,  125 cases organisms were isolated and taken up 
for the study, Out of 125 cases, 29 (23.2%) Aerobic organisms, 36 (28.8%) anaerobic 
organisms and 60 (48%) mixed organisms were isolated. 
GRAPH-1: TOTAL NUMBER OF AEROBIC, ANAEROBIC AND MIXED 
INFECTION  
*P<0.05 significant compared aerobics with anaerobic and mixed, #P<0.05 
significant compared anaerobic with mixed. This frequency of infection between the 
organisms was statistically significant.  
TABLE-2: TOTAL NUMBER OF INFECTIONS  
In this study, a total of 10 sites were found to be affected. Out of 125 cases, 
46cases were Vestibular Space followed by 24 Submandibular, 16 buccal, 10 canine, 8 
submassetric, 6 canine with buccal, 5 sublingual, 4 palatal space, Temporal and Ludwigs 
were affected in 3 cases each. In these infections most common site was vestibular space 
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followed by other spaces. This frequency of infection between the spaces was statistically 
significant.  
GRAPH-2: COMPARISON OF FREQUENCY AND PERCENTAGE OF TOTAL 
MICRO-ORGANISM ISOLATED  
125 cases organisms were isolated and taken up for the study, Out of 125 cases, 
29 (23.2%) Aerobic organisms, 36 (28.8%) anaerobic organisms and 60 (48%) mixed 
organisms were isolated. 
P<0.05 significant compared aerobics with anaerobic and mixed, P<0.05 
significant compared anaerobic with mixed. This frequency of infection between the 
organisms was statistically significant.  
TABLE-3: NUMBER, TYPE, FREQUENCY AND PERCENTAGE OF AEROBIC 
MICRO-ORGANISMS ISOLATED 
GRAPH-3: NUMBER AND PERCENTAGE OF AEROBIC ORGANISMS  
Table-3 and Graph-3 shows out of 29 aerobic organisms 10 (34.49%) were 
Streptococcus viridans and was the most common organism isolated followed by 6 
(20.69%) Staphylococcus aureus, 5 (17.25 %) Coagulase negative Staphylococcus, 4 
(13.79 %) Pseudomonas aeruginosa and both Escherichia coli and Klebsiella Pneumonia 
were isolated from 2 (6.89 %) specimens each.  
P<0.05 significant compared Streptococcus viridians with other organisms,   
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TABLE-4: NUMBER, TYPE, FREQUENCY AND PERCENTAGE OF 
ANAEROBIC MICRO-ORGANISMS ISOLATED  
GRPAH-4: NUMBER AND PERCENTAGE OF ANAEROBIC ORGANISMS 
Table-4 and Graph-4 shows anaerobic group of 36 organisms, 22 (61.11%) 
Peptostreptococcus and was the most common organism isolated followed by10 
(27.78%) Bacteroides, and 4 (11.11 %) Actinomyces. 
P<0.05 significant compared Peptostreptococcus with other organisms. 
TABLE-5: NUMBER, TYPE, FREQUENCY AND PERCENTAGE OF MIXED 
MICRO-ORGANISMS ISOLATED  
GRAPH-5: NUMBER AND PERCENTAGE OF MIXED MICRO-ORGANISM 
ISOLATED  
Table-5 and Graph-5 shows the number, type, frequency and percentage of mixed 
micro-organisms isolated. Streptococcus viridians with Peptostreptococcus were isolated 
from 18 (30%) cases and was the most common mixed organism isolated followed by 
Staphylococcus aureus with Peptostreptococcus in 12 (20%) cases, Streptococcus 
Viridans with Bacteroides in 9 (15 %) cases, Staphylococcus Aureus with Bacteroides in  
6 (10 %) cases, Coagulase negative staphylococcus with Bacteroides from 1 (1.67 %) 
cases, Streptococcus Viridans with Actinomyces in 8 (13.33 %) cases and Staphylococcus 
Aureus with Actinomyces in 6 (10 %) cases. P<0.05 significant compared Streptococcus 
viridians & Peptostreptococcus with other organisms. 
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TABLE-6: NUMBER AND PERCENTAGE OF CASES SENSITIVE AND 
RESISTANT TO SULFONAMIDES AND FLUROQUINOLONES  
GRAPH-6 AND GRAPH-7: NUMBER AND PERCENTAGE OF CASES 
SENSITIVE AND RESISTANT TO SULFONAMIDES AND 
FLUROQUINOLONES  
Table-6, Graph-6 and Graph-7 shows, sensitivity to Ofloxacin was 17 (58.62%) 
out of 29 aerobic organisms, 19 (52.77%) out of 36 anaerobes and 25 (41.66%) out of 60 
mixed organisms. Resistance to Ofloxacin was 12 (14.36%) out of 29 aerobic organisms, 
17 (47.22%) out of 36 anaerobic organisms and 35 (58.33%) out of 60 mixed organisms. 
Sensitivity to Levofloxacin was 12 (41.37%) out of 29 aerobes, 20 (55.55%) out of 36 
anaerobes and 31 (51.67%) out of 60 mixed organisms. Resistance to Levofloxacin was 
17 (58.62%) out of 29 aerobes, 16 (44.44%) out of 36 anaerobes and 29 (48.33%) out of 
60 mixed infections, followed by Gatifloxacin and norfloxacin and ciprofloxacin. 
Organisms showed least sensitivity and higher resistance towards Cotrimoxazole and 
sulfadiazine. 
P<0.05 significant compared Ofloxacin with other drugs. 
TABLE-7: NUMBER AND PERCENTAGE OF CASES SENSITIVE AND 
RESISTANT TO QUINOLONES GROUP 
Among Qunolones, all the aerobic, anaerobic and mixed organisms were resistant 
to Nalidixic acid. 
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TABLE-8: NUMBER AND PERCENTAGE OF CASES SENSITIVE AND 
RESISTANT TO AMINOGLYCOSIDE GROUP. 
GRAPH-8 AND GRAPH 9: NUMBER AND PERCENTAGE OF CASES  
SENSITIVE AND RESISTANT TO AMINOGLYCOSIDE GROUP. 
Table-8, Graph-8 and Graph-9 shows, among the Aminoglycoside group, out of 
29 aerobic organisms 5 (17.24%) were sensitive and 24 (82.76%) were resistant, out of 
36 cases of anaerobic organisms 3 (8.33%) were sensitive and 33 (91.67%) were resistant 
and for mixed organisms 12 (12%) were sensitive and 48 (80.00%) were resistant to 
Gentamycin followed by Amikacin and Neomycin. Streptomycin showed least sensitive 
and highest resistant. 
P<0.05 significant compared Gentamycin with other drugs in the group. 
TABLE-9: NUMBER AND PERCENTAGE OF CASES SENSITIVE AND 
RESISTANT TO MACROLIDE GROUP. 
GRAPH 10 AND GRAPH 11: NUMBER AND PERCENTAGE OF CASES 
SENSITIVE AND RESISTANT TO MACROLIDE GROUP. 
Table-9, Graph-10 and Graph-11 shows, among the Macrolide group organisms were 
least sensitive to Erythromycin (3.45%) and higher resistant (96.67%). But sensitivity to 
Azitromycin was 6 (20.69%) out of 29 aerobic organisms, 8(22.22%) out of 36 anaerobic 
organisms, and 18 (30%) out of mixed organisms. Resistance to Azitromycin was 23 
(79.31%) out of 29 aerobic organisms, 28 (77.78%) out of 36 anaerobic organisms and 42 
(70%) out of 60 mixed organisms followed by Roxithromycin. 
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P<0.05 significant compared Azitromycin with other drugs in the group. 
TABLE-10: NUMBER AND PERCENTAGE OF CASES SENSITIVE AND 
RESISTANT TO PENICILLIN GROUP. 
GRAPH 12 AND GRAPH 13: NUMBER AND PERCENTAGE OF CASES 
SENSITIVE AND RESISTANT TO PENICILLIN GROUP 
Table-10, Graph-12 and Graph-13 shows, among the pencillins group there was 
resistance to Amoxicillin in 28 (96.55%) out of 29 aerobic organisms, 31 (86.11%) out of 
36 anaerobic organisms and 58 (86.33%) of mixed organisms, followed by ampicillin, 
cloxacillin, pencillin, augmentin (amoxicillin with clavulenic acid) showed the highest 
resistance. On the other hand sensitivity to Piperacillin was 19 (65.52%) out of 29 aerobic 
organisms, 20 (55.56%) out of 36 anaerobic organisms and, 35(58.33%) out of 60 mixed 
organisms. Resistance to Piperacillin was 10 (27.78%) out of 29 aerobic organisms and 
16 (44.44%) out of 36 anaerobic organisms and 25 (41.67%) out of 60 mixed organisms.  
P<0.05 significant compared Piperacillin with other drugs in the group. 
TABLE-11: NUMBER AND PERCENTAGE OF CASES SENSITIVE AND 
RESISTANT TO CEPHALOSPORIN GROUP. 
GRAPH 14 AND GRAPH 15 : NUMBER AND PERCENTAGE OF CASES 
SENSITIVE AND RESISTANT TO CEPHALOSPORIN GROUP. 
Table-11, Graph-14 and Graph-15 shows, In Cephalosporins group, Sensitivity to 
Cefixime was 20 (68.97%) out of 29 aerobic organisms, 28 (77.78%) out of 36 anaerobic 
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organisms and 45 (75%) out of 60 mixed organisms. Resistance to Cefixime was 9 
(31.03%) out of 29 aerobic organisms, 8 (22.22%) out of 36 anaerobic organisms and 15 
(25%) out of 60 mixed organisms.  Sensitivity to Cefotaxime was 18 (62.07%) out of 29 
aerobic organisms, 24 (66.67%) out of 36 anaerobic organisms and 39 (65%) out of 60 
mixed organisms. Resistance to Cefotaxime was 11 (37.93%) out of 29 aerobic 
organisms, 12 (33.33%) out of 36 anaerobes and 21 (35%) out of 60 mixed organisms. 
Followed by ceftriaxone, cephalexin, cefradiazone, and the least sensitive in the group 
were cephpodoxime and cefazolin. 
P<0.05 significant compared Cefixime with other drugs in the group. 
TABLE-12: NUMBER AND PERCENTAGE OF CASES SENSITIVE AND 
RESISTANT TO BROAD SPECTRUM ANTIBIOTICS. 
GRAPH 16 AND GRAPH 17: NUMBER AND PERCENTAGE OF CASES 
SENSITIVE AND RESISTANT TO BROAD SPECTRUM ANTIBIOTICS 
Table-12, Graph-16 and Graph-17 shows, among the board spectrum antibiotics, 
organisms showed highest sensitivity and least resistance to Doxycyclin. Sensitivity to 
Doxycyclin was 15 (51.72%) out of 29 aerobes, 21 (58.33%) out of 36 anaerobic 
organisms and 34 (56.67%) out of mixed organisms. Resistance to doxycyclin was 14 
(48.27%) out of 29 aerobic organisms, 15 (41.67%) out of 36 anaerobic organisms and 26 
(43.33%) out of 60 mixed organisms.  There was highest resistance and least sensitivity 
towards Tetracycline, Chloramphenicol and Meropenem.   
P<0.05 significant compared Doxycyclin with other drugs in the group. 
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TABLE-13: NUMBER AND PERCENTAGE OF CASES SENSITIVE AND 
RESISTANT TO MISCELLANEOUS GROUP OF DRUGS. 
GRAPH 18 AND GRAPH 19: NUMBER AND PERCENTAGE OF CASES 
SENSITIVE AND RESISTANT TO MISCELLANEOUS GROUP OF DRUGS 
Table-13, Graph-18 and Graph-19 shows, Among the miscellaneous group of 
drugs, all the aerobic, anaerobic and mixed group of organisms was sensitive to Linezolid 
(100%). Entire anaerobic group were sensitive (100%) to Metronidazole and 39 (65%) 
out of 60 mixed organisms were sensitive to metronidazole. Resistance to metronidazole 
was 21 (35%) out of 60 mixed organisms. Entire aerobic group were Sensitive (100%) to 
Clindamycin, 30 (83.33%) out of 36 anaerobic groups were sensitive to clindamycin. 
And 38 (63.33%) out of 60 mixed organisms were sensitive to clindamycin.  Resistance 
to clindamycin was 6 (16.77%) out of 36 anaerobes. and 22 (36.67%) out of 60 mixed 
organisms.  Vancomycin and bacitracin showed highly resistant and least sensitive. 
Furoxone, Nitrofurantoin, Septran, Sporidex showed highly resistant. 
P<0.05 significant compared Linezolid with other drugs in the group. 
TABLE-14,15,&16: ANTIBIOTICS WHICH ARE SENSITIVE AND RESISTANT 
AGAINST AEROBIC, ANAEROBIC AND MIXED ORGANISMS 
Table number 14,15 and 16 shows the antibiotics which are sensitive and resistant to 
aerobic, anaerobic and mixed group of organisms. 
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Orofacial infections are caused by variety of bacteria. In vitro culture and 
antibiotic sensitivity testing should be routinely performed for proper antibiotic selection. 
Indiscriminate use and easy availability of antibiotics without prescription has probably 
contributed to the development of bacterial resistance. Presence of these refractory 
bacterial strains increases the importance of culture and sensitivity test to ensure that an 
effective antibiotic is prescribed that causes resolution of the infection. Present study 
conducted on a local population with head and neck fascial space infection helped to 
identify the causative microbiota and their sensitivity and resistance to commonly used 
antibiotics. 
Most odontogenic infections arise as a sequel to dental caries and periodontal 
infection. Most of the odontogenic infections resolve with little consequences although 
occasionally complications may lead to more severe infection of head and neck, 
particularly in immuno-compromised or debilitated patients14.  In the present study most 
of the source of odontogenic infections was grossly carious tooth, periodontal infection 
followed by pericoronitis.  
Oral infections spread in a pathway of least resistance often into the oral cavity or 
into the deep spaces of the neck, which may become life threatening. Deep-space 
infections originate most commonly from odontogenic sources in adults and from tonsil 
and other lymphatic sources in children. Spaces in the neck are created between the 
superficial, middle and deep layers of the deep cervical fascia. These spaces are 
interconnected15. 
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In the literature Submandibular space is the most commonly involved in multiple 
space infection followed by lateral pharyngeal, buccal and submental11, 23. This was 
supported by Opeyemi O. Daramola and Poeschl PW.23, 24.  In the present study of 125 
cases we also found Submandibular space (20%) to be the most commonly involved in 
multiple space infection. In our study Out of the single space infections, Vestibular Space 
46 (36.8%)showed more predisposition, deviating from literature by A.J Raga10 et al who 
said the Submandibular space was the most common location for a single-space abscess 
(30.0%). M. Sakaguchi (1997)21 reported peritonsillar space as the most common site.  
Thomas R Flynn (2006)22 reported highest occurrence of infection in the 
pterygomaxillary space. 
In the present study a total of 10 sites were found to be affected. Out of 125 cases, 
46 (36.8%) cases were Vestibular Space and were the followed by 24 (20%) 
Submandibular, 16 (12.8%) buccal, 10 (10%) canine, 8 (6.4%) submassetric, 6 (4.8%) 
canine and buccal, 5 (4%) sublingual, 4 (3.2%) palatal space, Temporal and Ludwigs 
were affected in 3 (2.4%) cases each. In these infections most common site was 
vestibular space and submandibular space followed by other spaces. 
The typical odontogenic infection is caused by a mixture of aerobic and anaerobic 
bacteria, approximately70% of these infections are caused by mixed flora. Pure aerobic 
bacteria are less common accounting for only 5%. Similarly pure anaerobic infections are 
approximately 25% of odontogenic infections25.   
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The present study also supports the similar results, In 125 cases, organisms were 
isolated. Out of 125 cases, 29 (23.2%) were aerobic organisms, 36 (28.8%) were 
anaerobic organisms and in 60 (48%) cases mixed organisms were isolated. This result 
also shows that the head and neck space infections of odontogenic origin are poly 
microbial in nature. According to the literature the most of the head and neck infections 
of odontogenic origin are of polymicrobial in nature1, 8, 9, 10, 11, 12, 13, 14, 15, 16.  
In the present study most of the infections are of mixed organisms 60(48%), 
followed by pure anaerobes in 36(28%) and pure aerobes in 29(23.3%) cases. Andrew 
Bridgeman13 in 1995 states that Odontogenic maxillofacial infections consist of aerobic, 
facultative anaerobic and obligate anaerobic bacteria with the aerobes and facultative 
anaerobes being outnumbered by strict anaerobic bacteria by a factor of at least 2:l with 
streptococci predominate. Timothy M. Osborn26 in 2008 also reports that anaerobic 
bacteria are found to be more in odontogenic infections. J. E. Turner33, et al in 1975 
reported that aerobes predominate in odontogenic infections.  
In this study, out of 125 cases, pure aerobic organisms caused infection in 29 
cases. Out of this, 10 (34.49%) were Streptococcus viridians followed by Staphylococcus 
aureus 6 (20.69%) cases, Coagulase negative Staphylococcus 5 (17.25 %) cases, 
Pseudomonas Aeruginosa 4 (13.79 %) cases, and both Escherichia coli and Klebsiella 
Pneumonia were isolated from 2 (6.89 %) specimens each.  
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In our study anaerobic group, out of 36 cases, 22 (61.11%) were 
Peptostreptococcus followed by10 (27.78%) Bacteroides, and 4 (11.11 %) Actinomyces. 
Mixed species found were Streptococcus viridians with Peptostreptococcus isolated from 
18 (30%) cases and was the most common mixed organism isolated followed by 
Staphylococcus aureus with Peptostreptococcus in 12 (20%) cases, Streptococcus 
Viridans with Bacteroides in 9 (15 %) cases, Staphylococcus Aureus with Bacteroides in  
6 (10 %) cases, Coagulase negative staphylococcus with Bacteroides in 1 (1.67 %) cases, 
Streptococcus Viridans with Actinomyces in 8 (13.33 %) cases and Staphylococcus 
Aureus with Actinomyces in 6 (10 %) cases. 
According to the literature it has been found  that Streptococus viridians  was the 
most common pathogens in the head and neck space infections1,10, 19,21,26, 27, 28, 29, 30,33,51 
and in our study Streptococus viridians  was also found to be the most common 
microorganism. The second most common microorganism isolated was the 
Staphylococcus aureus 5 (17.25 %). These results were also supported by previous 
studies7, 34, 35. 
The third most common micro organism isolated in this study was Coagulase 
negative Staphylococcus 4 (13.79 %) which was found an important source of 
nosocomial infections. Methicillin resistant Coagulase negative Staphylococci is 
associated with prophylactic and therapeutic use of cephalosporins (Laith Hussein et al. 
(2010)36. In our study, we found significant level of resistance to commonly used 
antibiotics in (6%) Coagulase negative Staphylococci. 
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The two most popular theories for the origin of antibiotic resistance are. (1) 
Resistance may be either inherits or (2) it may be acquired by the processes of genetic 
mutation or gene transfer.17, 18 
Mechanism of acquired resistance falls into one of the five categories, although 
bacteria may employ more than one mechanism17, 18, 36 
1. Alteration of drugs target site 
2. Inability of a drug to reach the target site  
3. Inactivation of an antimicrobial agent 
4. Active elimination of an antibiotic from the cell 
Specific mechanisms by which bacteria acquire resistance genes are17 
1. Spontaneous mutation 
2. Gene transfer 
3. Bacteriophages 
4. Mosaic genes 
Therefore proper selection of antibiotics has a twofold benefit: (1) the rapid 
elimination of infection, which decreases the extent of tissue destruction; and (2) 
diminishing the use of improper antibiotics to prevent the development of antibiotic 
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resistance. In addition to becoming familiar with the indigenous microbiota of oral cavity, 
the patient’s immune status, allergy profile, and previous antibiotic usage that may 
predispose to resistant organisms need to be considered15. The antibiotics chosen by the 
surgeon must be effective against microbes that are most likely to cause abscess in 
orofacial region and it should decrease the development of bacterial resistance. Usually 
most of the odontogenic infections are successfully managed by incision and drainage, 
together with extraction or root canal therapy and proper antibiotic regime37, 38, 39. 
However sometimes infections from these spaces may spread into other danger spaces 
leading to life threatening  conditions. Timely and deliberate efforts to establish 
debridement and drainage as well as appropriate antibiotic therapy should be initiated by 
the surgeon.4 
 The laboratory data regarding microbiological flora, antibiotic susceptibility are 
crucial information for the clinician who is considering the administration of antibiotic 
therapy. However it may take several days to obtain such data. Hence antibiotics are 
chosen empirically. 
Penicillin has been the antibiotic of choice for most odontogenic 
infections12,13,14,34,37.  But resistant organisms have developed due to its long and 
widespread use40, 41, 42, 43.  Although penicillin remains the antibiotic of choice for mild to 
moderate odontogenic infections in the immunocompetent host but pencillin should not 
be used as initial therapy for more serious infections possibly involving penicillin 
resistant oral anaerobes45. 
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In our center Amoxicillin with Metronodazole were the most common empirical 
antibiotics prescribed to patients with odontogenic infections.  And in our study among 
the pencillins group, there was resistance to Amoxicillin in 28 (96.55%) out of 29 aerobic 
organisms, 31 (86.11%) out of 36 anaerobic organisms and 58 (86.33%) of mixed 
organisms, followed by Ampicillin, Cloxacillin, Pencillin, Augmentin (amoxicillin with 
clavulenic acid) showed the highest resistance. On the other hand sensitivity to 
Piperacillin was 19 (65.52%) out of 29 aerobic organisms, 20 (55.56%) out of 36 
anaerobic organisms and, 35(58.33%) out of 60 mixed organisms. Resistance to 
Piperacillin was 10 (27.78%) out of 29 aerobic organisms and 16 (44.44%) out of 36 
anaerobic organisms and 25 (41.67%) out of 60 mixed organisms.  
In this study among the Macrolide group, organisms were least sensitive to 
Erythromycin (3.45%) and higher resistance (96.67%). But sensitivity to Azitromycin 
was 6 (20.69%) out of 29 aerobic organisms, 8(22.22%) out of 36 anaerobic organisms, 
and 18 (30%) out of mixed organisms. Resistance to Azitromycin was 23 (79.31%) out of 
29 aerobic organisms, 28 (77.78%) out of 36 anaerobic organisms and 42 (70%) out of 60 
mixed organisms followed by Roxithromycin. This high resistance to macrolides was 
supported by Paul. W. Poeschl et al. in 201048, he concluded that the high resistance rate 
for macrolides was especially striking and may necessitate an adoption of newer 
antibiotic regime in the future. 
In our study among the fluroqunolones, organisms showed highest sensitivity 
towards Ofloxacin and Levofloxacin.  Sensitivity to Ofloxacin was 17 (58.62%) out of 29 
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aerobic organisms, 19 (52.77%) out of 36 anaerobes and 25 (41.66%) out of 60 mixed 
organisms. Resistance to Ofloxacin was 12 (14.36%) out of 29 aerobic organisms, 17 
(47.22%) out of 36 anaerobic organisms and 35 (58.33%) out of 60 mixed organisms. 
Sensitivity to Levofloxacin was 12 (41.37%) out of 29 aerobes, 20(55.55%) out of 36 
anaerobes and 31(51.67%) out of 60 mixed organisms. Resistance to Levofloxacin was 
17 (58.62%) out of 29 aerobes, 16 (44.44%) out of 36 anaerobes and 29 (48.33%) out of 
60 mixed infections, followed by Gatifloxacin and norfloxacin and ciprofloxacin. 
Organisms showed least sensitivity and higher resistance towards Cotrimoxazole and 
sulfadiazine. This result was supported by Munish Kohli47 et al in 2009 in his study 
Ofloxacin was the most sensitive drug. The most resistant drugs were amoxicillin and 
ampicillin. The gram negative colonies were sensitive to cefotaxime.  
  In our study, among aminoglycosides 5 (17.24%) out of 29 aerobic organisms, 3 
(8.33%) out of 36 anaerobic organisms and 12 (12%) out of 60 mixed organisms were 
sensitive to Gentamycin.  Resistance to Gentamycin was noted in 24 (82.76%) out of 29 
aerobes, 33 (91.67%) out of 36 anaerobes, and 48 (80.00%) out of 60 mixed organisms, 
Streptomycin showed least sensitive and highest resistant.  
In the present study among Cephalosporins group, Sensitivity to Cefixime was 20 
(68.97%) out of 29 aerobic organisms, 28 (77.78%) out of 36 anaerobic organisms and 45 
(75%) out of 60 mixed organisms. Resistance to Cefixime was 9 (31.03%) out of 29 
aerobic organisms, 8 (22.22%) out of 36 anaerobic organisms and 15 (25%) out of 60 
mixed organisms.  Sensitivity to Cefotaxime was 18 (62.07%) out of 29 aerobic 
organisms, 24 (66.67%) out of 36 anaerobic organisms and 39 (65%) out of 60 mixed 
organisms. Resistance to Cefotaxime was 11 (37.93%) out of 29 aerobic organisms, 12 
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(33.33%) out of 36 anaerobes and 21 (35%) out of 60 mixed organisms. Followed by 
ceftriaxone, cephalexin, cefradiazone, and the least sensitive in the group were 
cephpodoxime and cefazolin. 
  Among the board spectrum antibiotics, organisms showed highest sensitivity and 
least resistance to Doxycyclin. Sensitivity to Doxycyclin was 15 (51.72%) out of 29 
aerobes, 21 (58.33%) out of 36 anaerobic organisms and 34 (56.67%) out of mixed 
organisms. Resistance to doxycyclin was 14 (48.27%) out of 29 aerobic organisms, 15 
(41.67%) out of 36 anaerobic organisms and 26 (43.33%) out of 60 mixed organisms.  
There was highest resistance and least sensitivity towards Tetracycline, Chloramphenicol 
and Meropenem.   
Among the miscellaneous group of drugs, all the aerobic, anaerobic and mixed 
group of organisms was sensitive to Linezolid (100%). Entire anaerobic group were 
sensitive (100%) to Metronidazole and 39 (65%) out of 60 mixed organisms were 
sensitive to metronidazole. Resistance to metronidazole was 21 (35%) out of 60 mixed 
organisms. Entire aerobic group were Sensitive (100%) to Clindamycin, 30 (83.33%) out 
of 36 anaerobic groups were sensitive to clindamycin. And 38 (63.33%) out of 60 mixed 
organisms were sensitive to clindamycin.  Resistance to clindamycin was 6 (16.77%) out 
of 36 anaerobes and 22 (36.67%) out of 60 mixed organisms.  Vancomycin and bacitracin 
showed high resistance and least sensitivity. Furoxone, Nitrofurantoin, Septran, Sporidex 
showed high resistance to all the group of drugs.  John G. Bartlett49 et al in 1975 reported 
that Clindamycin proved equally effective in anaerobic pulmonary infections and in his 
study there were no therapeutic failures reported with clindamycin. 
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Vejayan Krishnan, in 19934 described that pencillin resistant organisms have 
developed due to its long and widespread use so that Clindamycin became preferred 
antibiotic for empiric therapy in his study. In literature, lots of reports about the resistance 
of Amoxycillin and alternative antibiotic should be replaced such as Clindamycin 8, 21,22. 
Even clindamycin failure with penicillin therapy and a rate of penicillin resistance also 
has been reported. 
Specificity of empirical antibiotic therapy could be improved with good 
knowledge about the pathologic flora in the locality. This will help in administration of 
appropriate antibiotics instantaneously to control the infection. This will counter the 
delay in identification of the causative agent and specific antibiotic therapy.  
Summary& Conclusion 
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This study was aimed at identifying the major causative aerobic and anaerobic 
micro organisms involved in head and neck fascial space infections of odontogenic origin 
and their sensitivity and resistance to commonly used antibiotics. 
 
The study showed most of the head and neck fascial space infections are of 
odontogenic origin and are polymicrobial in nature, majority being mixed organisms and 
more than one half are pure anaerobes. The most common aerobic organism isolated was 
Streptococcus viridians, most common anaerobe was Peptostreptococci, and the most 
common mixed organism was Streptococcus with Peptostreptococci.  
 
Amoxicillin was the most commonly used empirical antibiotic in all the cases and 
showed highest resistance for all organisms. But all the aerobic, anaerobic and mixed 
group of organisms was sensitive to Linezolid. The entire anaerobic group showed 
sensitive to Metronidazole. The entire aerobic group showed sensitive to Clindamycin. 
Among Fluroquinolones organisms showed highest sensitivity towards Ofloxacin, 
Levofloxacin and Cefixime and Cefotaxime among Cephalosporins group. 
 
According to the study there should be substitution of miscellaneous group of 
antibiotics such as Linezolid, Clindamycin, third generation cephalosporins such as 
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cefixime, cefotaxime, and fluroqunolones such as Ofloxacin and Levofloxacin for 
Amoxicillin in the empirical management of deep fascial space infections. Hence 
successful management of head and neck fascial space infections of odontogenic origin 
can be achieved by appropriate surgical intervention to establish drainage, good overall 
supportive care of the patient, gram staining of purulent exudates  to provide  immediate 
information needed for the rational selection of an antibiotic  and in vitro microbiological 
culture and antibiotic susceptibility.  
 
It can be concluded that the knowledge about the pathologic flora involved in 
head and neck infection in a locality and their sensitivity and resistance to commonly 
used antibiotics will help the clinician in administering appropriate antibiotics at the 
earliest phase of infection, which will adequately control the infection and hence 
minimizing the morbidity.  
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Table-1: Distribution of   Odontogenic Infection 
S. 
No 
Place Aerobic Anaerobic Mixed 
Number Percentage  Number Percentage  Number Percentage  
1 Vestibular Space 10 34.48 14 38.44 22 36.67 
2 Sub Mandibular Space 6 20.68 8 22.22 10 16.66 
3 Buccal Space 3 10.34 4 11.11 9 15.00 
4 Canine Space 2 6.90 3 8.33 5 8.33 
5 Sub Massetric Space 2 6.90 2 5.55 4 6.67 
6 Canine and Buccal Space 2 6.90 1 2.78 3 5.00 
7 Sub lingual Space 1 3.45 1 2.78 3 5.00 
8 Palatal Space 1 3.45 1 2.78 2 3.33 
9 Ludwigs Angina 1 3.45 1 2.78 1 1.67 
10 Temporal Space 1 3.45 1 2.78 1 1.67 
 Total 29 100 36 100 60 100 
 
 
Table-2: Total number of Infections 
S. No Site  Total number  
1 Vestibular Space 46 
2 Sub Mandibular Space 24 
3 Buccal Space 16 
4 Canine Space 10 
5 Sub Massetric Space 8 
6 Canine and Buccal Space 6 
7 Sub lingual Space 5 
8 Palatal Space 4 
9 Ludwigs Angina 3 
10 Temporal Space 3 
 Total 125 
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Table-3: Number, type, frequency and percentage of aerobic micro-organisms 
isolated 
S. No. Aerobic Organisms Frequency Percentage (%) 
1 Streptococcus Viridans 10 34.49 
2 Staphylococcus Aureus 6 20.69 
3 Coagulase negative staphylococcus 5 17.25 
4 Pseudomonas Aeroginosa 4 13.79 
5 E. Coil 2 6.89 
6 Klebsiella  Pneumonia 2 6.89 
 Total 29 100 
 
 
 
Table-4: Number, type, frequency and percentage of Anaerobic micro-organisms 
isolated 
Sl. No Anaerobic Organisms Frequency Percentage (%) 
1 Peptostreptococcus 22 61.11 
2 Bacteroides 10 27.78 
3 Actinomyces 4 11.11 
 
Total 36 100 
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Table-5: Number, type, frequency and percentage of mixed micro-organisms 
isolated 
S. No Mixed Organism Frequency Percentage (%) 
1 Streptococcus Viridans + Peptostreptococcus 18 30.00 
2 Staphylococcus Aureus + Peptostreptococcus 12 20.00 
3 Streptococcus Viridans + Bacteroides 9 15.00 
4 Staphylococcus Aureus + Bacteroides 6 10.00 
5 Coagulase negative staphylococcus + Bacteroides 1 1.67 
6 Streptococcus Viridans + Actinomyces 8 13.33 
7 Staphylococcus Aureus + Actinomyces 6 10.00 
 Total 60 100 
 
Table-6: Number and percentage of cases sensitive and resistant to Sulfonamides 
and Fluroquinolones  
Drug 
Aerobic Anaerobic Mixed 
Sensitive Resistant Sensitive Resistant Sensitive Resistant 
No % No % No % No % No % No % 
Ofloxacin 17 58.62 12 14.36 19 52.77 17 47.22 25 41.66 35 58.33 
Ciprofloxacin 2 6.89 27 93.10 0 0 36 100 3 5.00 57 95.00 
Cotrimoxazole 0 0 29 100 0 0 36 100 0 0 60 100 
Norfloxacin 3 10.34 26 89.65 2 5.55 34 94.44 7 11.67 53 88.33 
Sulfadiazine 0 0 29 100 0 0 36 100 1 1.67 59 98.33 
Gatifloxacin 6 20.68 23 79.31 3 8.33 33 91.67 9 15.00 51 85.00 
Levofloxacin 12 41.37 17 58.62 20 55.55 16 44.44 31 51.67 29 48.33 
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Table-7: Number and percentage of cases sensitive and resistant to Quinolone group 
Drug 
Aerobic Anaerobic Mixed 
Sensitive Resistant Sensitive Resistant Sensitive Resistant 
No % No % No % No % No % No % 
Nalidixic acid 0 0 29 100 0 0 36 100 0 0 60 100 
 
 
 
Table-8: Number and percentage of cases sensitive and resistant to Aminoglycoside 
group 
Drug 
Aerobic Anaerobic Mixed 
Sensitive Resistant Sensitive Resistant Sensitive Resistant 
No % No % No % No % No % No % 
Amikacin 4 13.79 25 86.21 7 19.44 29 80.55 10 16.67 50 83.33 
Gentamycin 5 17.24 24 82.76 3 8.33 33 91.67 12 20.00 48 80.00 
Neomycin 1 3.45 28 96.55 2 5.55 34 94.44 5 8.33 55 91.67 
Streptomycin 0 0 29 100 0 0 36 100 0 0 60 100 
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Table-9: Number and percentage of cases sensitive and resistant to Macrolide group 
Drug 
Aerobic Anaerobic Mixed 
Sensitive Resistant Sensitive Resistant Sensitive Resistant 
No % No % No % No % No % No % 
Erythromycin 1 3.45 28 96.55 0 0 36 100 2 3.33 58 96.67 
Azithromycin 6 20.69 23 79.31 8 22.22 28 77.78 18 30.00 42 70.00 
Roxithromycin 4 13.79 25 86.21 5 13.89 31 86.11 10 16.67 50 83.33 
 
 
Table-10: Number and percentage of cases sensitive and resistant to Penicillin group 
Drug 
Aerobic Anaerobic Mixed 
Sensitive Resistant Sensitive Resistant Sensitive Resistant 
No % No % No % No % No % No % 
Amoxicillin 1 3.44 28 96.55 5 13.89 31 86.11 7 11.67 53 88.33 
Ampicillin 1 3.44 28 96.55 1 2.78 35 97.22 3 5.00 57 95.00 
Piperacillin 19 65.52 10 27.78 20 55.56 16 44.44 35 58.33 25 41.67 
Cloxacillin 1 3.44 28 96.55 3 8.33 33 91.67 3 5.00 57 95.00 
Penicillin 1 3.44 28 96.55 0 0 36 100 0 0 60 100 
Augmentin 2 6.89 27 93.10 0 0 36 100 1 1.67 59 98.33 
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Table-11: Number and percentage of cases sensitive and resistant to Cephalosporin 
group 
Drug 
Aerobic Anaerobic Mixed 
Sensitive Resistant Sensitive Resistant Sensitive Resistant 
No % No % No % No % No % No % 
Cefotaxime 18 62.07 11 37.93 24 66.67 12 33.33 39 65.00 21 35.00 
Cefixime 20 68.97 9 31.03 28 77.78 8 22.22 45 75.00 15 25.00 
Cephalexin 3 10.34 26 89.66 1 2.78 35 97.22 5 8.33 55 91.67 
Cefpodoxime 1 3.45 28 96.55 1 2.78 35 97.22 3 5.00 57 95.00 
Cefradiazone 1 3.45 28 96.55 3 8.33 33 91.67 3 5.00 57 95.00 
Cefazolin 1 3.45 28 96.55 1 2.78 35 97.22 3 5.00 57 95.00 
Ceftriaxone 1 3.45 28 96.55 5 13.89 31 86.11 5 8.33 55 91.67 
 
 
Table-12: Number and percentage of cases sensitive and resistant to Broad 
spectrum antibiotics 
Drug 
Aerobic Anaerobic Mixed 
Sensitive Resistant Sensitive Resistant Sensitive Resistant 
No % No % No % No % No % No % 
Chloramphenicol 1 3.45 28 77.78 0 0 36 100 2 3.33 58 96.67 
Doxycycline 15 51.72 14 48.27 21 58.33 15 41.67 34 56.67 26 43.33 
Meropenem 1 3.45 27 75.00 2 5.56 34 94.44 5 8.33 55 91.67 
Tetracycline 1 3.45 27 75.00 1 2.78 35 97.22 4 6.67 56 93.33 
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Table-13: Number and percentage of cases sensitive and resistant to miscellaneous 
group of drugs 
Drug 
Aerobic Anaerobic Mixed 
Sensitive Resistant Sensitive Resistant Sensitive Resistant 
No % No % No % No % No % No % 
Linezolid 29 100 0 0 36 100 0 0 60 100 0 0 
Metronidazole 0 0 29 100 36 100 0 0 39 65.00 21 35.00 
Vancomycin 1 3.45 28 96.55 1 2.78 35 97.22 3 5.00 57 95.00 
Bacitracin 1 3.45 28 96.55 10 27.78 26 72.22 20 33.33 40 66.67 
Clindamycin 29 100 0 0 30 83.33 6 16.67 38 63.33 22 36.67 
Furoxone 0 0 29 100 0 0 36 100 0 0 60 100 
Nitrofurantoin 0 0 29 100 0 0 36 100 0 0 60 100 
Septran 0 0 29 100 0 0 36 100 0 0 60 100 
Sporidex 0 0 29 100 0 0 36 100 0 0 60 100 
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Table-14: Antibiotics which are sensitive and resistant agonist aerobic organisms. 
S. No Microorganisms Sensitive Resistant 
1. Streptococcus 
Viridans 
Ofloxacin, Norfloxacin 
Gatifloxacin, 
Levofloxacin, Gentamicin, 
Azithromycin, 
Roxithromycin, 
Piperacillin, Cloxacillin, 
Meropenem, Cefotaxime, 
Cefixime, Cefuroxime, 
Cefpodoxime, 
Doxycycline, 
Clindamycin. 
Sulfadiazine, Nalidixic acid, 
Ciprofloxacin, Cotrimoxazole, 
Amikacin, Neomycin, Streptomycin, 
Erythromycin, Ampicillin, 
Amoxicillin, Penicillin, Augmentin 
Cephalexin, Ceftazidime, Cefazolin, 
Tetracycline, Chloramphenicol, 
Bacitracin, Vancomycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
2. Staphylococcus 
Aureus 
Gatifloxacin, Norfloxacin, 
Ofloxacin, Levofloxacin, 
Gentamicin, 
Azithromycin, 
Roxithromycin, 
Cloxacillin, Cefotaxime, 
Cefixime, Cefuroxime, 
Cefpodoxime, 
Doxycycline, Linezolid, 
Clindamycin. 
Sulfadiazine, Nalidixic acid, 
Ciprofloxacin, Cotrimoxazole, 
Amikacin, Neomycin, Streptomycin, 
Erythromycin, Ampicillin, 
Amoxicillin, Penicillin, Piperacillin, 
Augmentin, Cephalein, Ceftazidime,  
Cefazolin, Tetracycline, Meropenem, 
Chloramphenicol, Bacitracin, 
Vancomycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
3. Pseudomonas 
Aeruginosa  
Ofloxacin, Gentamicin, 
Amikacin, Roxithromycin, 
Piperacillin, Cefotaxime, 
Cefixime Cefradiazone, 
Levofloxacin, 
Doxycycline, Linezolid, 
Clindamycin. 
Sulfadiazine, Nalidixic acid, 
Gatifloxacin Ciprofloxacin, 
Norfloxacin Cotrimoxazole, 
Neomycin, Streptomycin, 
Erythromycin Azithromycin, 
Ampicillin, Amoxicillin, Penicillin, 
Augmentin, Cloxacillin, Cephalein, 
Cefpodoxime, Cefazolin, 
Cefuroxime, Tetracycline, 
Chloramphenicol,  Meropenem, 
Bacitracin, Vancomycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
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4. E. coil Ofloxacin, Norfloxacin, 
Gentamicin, Amikacin, 
Roxithromycin, 
Azithromycin, Piperacillin, 
Cloxacillin, Cefotaxime, 
Cefpodoxime, 
Cefradiazone, Cefixime, 
Levofloxacin, 
Doxycycline, 
Clindamycin, Linezolid. 
Sulfadiazine, Nalidixic acid 
Gatifloxacin Cotrimoxazole, 
Ciprofloxacin, Neomycin, 
Streptomycin, Erythromycin, 
Ampicillin, Amoxicillin, Penicillin, 
Augmentin, Cephalein, Cloxacillin, 
Cefazolin Cefuroxime, Tetracycline, 
Chloramphenicol,  Meropenem, 
Bacitracin, Vancomycin, , Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
5.  Klebsiella  
Pneumonia 
Ofloxacin, Ciprofloxacin, 
Gentamicin, Cefotaxime, 
Cefixime, Cefradiazone, 
Levofloxacin, Linezolid, 
Clindamycin, 
Doxycycline. 
Sulfadiazine, Nalidixic acid 
Norfloxacin, Gatifloxacin, 
Cotrimoxazole, Amikacin, 
Neomycin, Streptomycin, 
Erythromycin Azithromycin, 
Roxithromycin, Ampicillin, 
Amoxicillin, Penicillin, Augmentin 
Cloxacillin Piperacillin, Cephalein, 
Cefotaxime,  Cefazolin, Cefuroxime, 
Tetracycline, Chloramphenicol, 
Meropenem, Bacitracin, 
Vancomycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
6. Coagulase 
negative 
staphylococcus 
Ciprofloxacin, 
Gentamicin, Neomycin, 
Cefotaxime, Cefixime 
Cefradiazone, 
Cefpodoxime, 
Doxycycline, Linezolid, 
Clindamycin. 
Sulfadiazine, Nalidixic acid, 
Ofloxacin,  Norfloxacin, Gatifloxacin 
Cotrimoxazole, Amikacin, 
Streptomycin, Erythromycin 
Azithromycin, Roxithromycin, 
Ampicillin, Amoxicillin, Penicillin, 
Augmentin Cloxacillin, Cephalein, 
Cefazolin Cefuroxime, Tetracycline, 
Levofloxacin, Chloramphenicol,  
Meropenem, Bacitracin, 
Vancomycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex.  
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Table-15: Antibiotics which are sensitive and resistant agonist anaerobic organisms.  
S. 
No 
Microorganisms Sensitive Resistant 
1. Peptostreptococcus Gatifloxacin, Gentamicin, 
Amikacin, Azithromycin, 
Roxithromycin, 
Cloxacillin, Cefotaxime, 
Cefixime, Levofloxacin, 
Linezolid, Bacitracin, 
Metronidazole, 
Clindamycin. 
 
Sulfadiazine, Nalidixic acid 
Ciprofloxacin, Ofloxacin, 
Norfloxacin, Cotrimoxazole, 
Neomycin, Streptomycin, 
Erythromycin, Ampicillin, 
Amoxicillin, Penicillin, Augmentin 
Piperacillin, Cephalein, 
Cefradiazone, Cefazolin, 
Cefuroxime, Cefpodoxime, 
Tetracycline, Meropenem 
Doxycycline, Chloramphenicol, 
Vancomycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
2. Bacteroides Azithromycin, Bacitracin, 
Roxithromycin, 
Amoxicillin, Ceftriaxone, 
Cefotaxime, Cefixime, 
Levofloxacin, 
Meropenem, Linezolid, 
Metronidazole, 
Clindamycin. 
  
Sulfadiazine, Nalidixic acid 
Ofloxacin, Ciprofloxacin, Sporidex, 
Cotrimoxazole Norfloxacin, 
Gatifloxacin, Amikacin, Neomycin, 
Streptomycin, Gentamicin, Septran 
Erythromycin, Cloxacillin, 
Ampicillin, Penicillin, Piperacillin, 
Augmentin, Cephalein, Cefradiazone, 
Cefazolin, Cefuroxime, Furoxene 
Cefpodoxime, Tetracycline, 
Doxycycline, Chloramphenicol, 
Vancomycin, Nitrofurantoin. 
3. Actinomyces Ofloxacin, Ciprofloxacin, 
Gentamicin, Amikacin, 
Neomycin, 
Roxithromycin, 
Azithromycin, 
Piperacillin, Amoxicillin, 
Cefotaxime, 
Cefradiazone, 
Levofloxacin, Bacitracin, 
Linezolid, Metronidazole. 
Sulfadiazine, Nalidixic acid,  
Norfloxacin, Gatifloxacin, Sooridex, 
Cotrimoxazole, Streptomycin 
Erythromycin, Ampicillin, Penicillin, 
Augmentin Cloxacillin, Cephalein, 
Cefpodoxime, Cefazolin Cefuroxime, 
Cefixime, Tetracycline, Doxycycline, 
Chloramphenicol, Meropenem, 
Vancomycin, Clindamycin, 
Furoxone, Nitrofurantoin, Septran. 
 
 
Tables 
 
  XIX 
 
Table-16: Antibiotics which are sensitive and resistant against mixed organisms. 
S. No Mixed infection Sensitive Resistant 
1. Streptococcus 
Viridans + 
Peptostreptococcus 
Ofloxacin, Norfloxacin, 
Gatifloxacin, Gentamicin, 
Amikacin, Roxithromycin, 
Azithromycin, Piperacillin, 
Cloxacillin, Cefotaxime, 
Cefixime Cefpodoxime, 
Cefuroxime, Levofloxacin, 
Doxycycline, Meropenem, 
Bacitracin, Clindamycin,  
Linezolid, Metronidazole. 
Sulfadiazine, Nalidixic acid 
Cotrimoxazole, Ciprofloxacin, 
Streptomycin, Neomycin, 
Erythromycin, Amoxicillin, 
Ampicillin, Penicillin, 
Augmentin, Cephalein, Cefazolin 
Cefradiazone, Tetracycline, 
Chloramphenicol, Vancomycin, 
Furoxone, Nitrofurantoin, 
Septran, Sporidex. 
2. Staphylococcus 
Aureus + 
Peptostreptococcus 
Sulfadiazine, Norfloxacin, 
Gatifloxacin, Gentamicin, 
Amikacin, Roxithromycin, 
Azithromycin, Cloxacillin, 
Cefotaxime, Cefixime, 
Cefpodoxime, Cefuroxime, 
Levofloxacin, Meropenem, 
Bacitracin, Linezolid, 
Metronidazole. 
 
Nalidixic acid, Ofloxacin, 
Cotrimoxazole, Ciprofloxacin, 
Streptomycin, Neomycin, 
Erythromycin, Amoxicillin, 
Ampicillin, Piperacillin, 
Penicillin, Augmentin, Cephalein, 
Cefazolin, Cefradiazone, 
Tetracycline, Doxycycline, 
Chloramphenicol, Vancomycin, 
Clindamycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
3. Streptococcus 
Viridans + 
Bacteroides 
Norfloxacin, Ofloxacin, 
Gatifloxacin, Gentamicin, 
Roxithromycin, Liezolid, 
Azithromycin, Cloxacillin, 
Amoxicillin, Piperacillin, 
Cefotaxime , 
Cefpodoxime, Cefuroxime, 
Levofloxacin, Meropenem, 
Doxycycline, Bacitracin, 
Metronidazole. 
Sulfadiazine, Amikacin, 
Streptomycin, Neomycin, 
Erythromycin, Ampicillin, 
Penicillin, Augmentin, Cefixime, 
Cephalein, Cefazolin 
Cefradiazone, Tetracycline, 
Chloramphenicol, Vancomycin, 
Clindamycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
4. Staphylococcus 
Aureus + 
Bacteroides 
Norfloxacin, Gatifloxacin, 
Roxithromycin, 
Gentamicin, Cloxacillin, 
Amoxicillin, Cefotaxime, 
Cefixime, Cefpodoxime, 
Cefuroxime, Levofloxacin, 
Meropenem, Bacitracin, 
Sulfadiazine, Nalidixic acid 
Cotrimoxazole Ofloxacin,, 
Ciprofloxacin, Amikacin, 
Streptomycin, Neomycin, 
Erythromycin, Azithromycin, 
Piperacillin, Ampicillin, 
Penicillin, Augmentin, Cephalein, 
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Linezolid, Metronidazole. 
 
Cefazolin Cefradiazone, 
Tetracycline, Chloramphenicol,  
Doxycycline, Vancomycin, 
Clindamycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
5.  Coagulase negative 
staphylococcus + 
Bacteroides 
Ciprofloxacin, Gentamicin, 
Azithromycin, Cloxacillin, 
Piperacillin, Bacitracin, 
Linezolid, Metronidazole, 
Levofloxacin, Meropenem, 
Cefotaxime, Cefuroxime, 
Levofloxacin, Meropenem, 
Bacitracin, Linezolid, 
Metronidazole. 
 
 
Sulfadiazine, Nalidixic acid 
Norfloxacin, Ofloxacin, 
Cotrimoxazole, Gatifloxacin,  
Amikacin, Streptomycin, 
Neomycin, Roxithromycin, 
Erythromycin, Tetracycline, 
Doxycycline, Chloramphenicol, 
Cefpodoxime, Cephalein, 
Cefixime, Cefazolin, 
Cefradiazone, Ampicillin, 
Penicillin, Augmentin, 
Amoxicillin, Cefpodoxime, 
Cephalein, Cefixime, Cefazolin 
Cefradiazone, Tetracycline, 
Doxycycline, Chloramphenicol, 
Vancomycin, Clindamycin, 
Furoxone, Nitrofurantoin, 
Septran, Sporidex. 
6. Streptococcus 
Viridans + 
Actinomyces 
Sulfadiazine, Norfloxacin, 
Ofloxacin, Gatifloxacin, 
Gentamicin, Neomycin, 
Roxithromycin, 
Azithromycin, Cloxacillin, 
Piperacillin, Cefotaxime, 
Cefixime, Cefpodoxime, 
Cefradiazone, 
Levofloxacin, 
Doxycycline, Bacitracin, 
Linezolid, Metronidazole. 
Nalidixic acid, Cotrimoxazole, 
Ciprofloxacin, Erythromycin, 
Amoxicillin, Ampicillin, 
Penicillin, Augmentin, Cephalein, 
Cefazolin, Cefuroxime, 
Tetracycline, Meropenem, 
Chloramphenicol, Vancomycin, 
Clindamycin, Furoxone, 
Nitrofurantoin, Septran, Sporidex. 
7.  Staphylococcus 
Aureus + 
Actinomyces 
Norfloxacin, Ofloxacin, 
Gatifloxacin, 
Ciprofloxacin, Gentamicin, 
Neomycin, Roxithromycin, 
Cloxacillin, Piperacillin, 
Cefotaxime, Cefixime, 
Cefuroxime, Levofloxacin, 
Doxycycline, Bacitracin, 
Sulfadiazine, Nalidixic acid, 
Cotrimoxazole, Amikacin, 
Streptomycin, Azithromycin, 
Erythromycin, Amoxicillin, 
Ampicillin, Penicillin, 
Augmentin, Cephalein, 
Cefpodoxime, Cefazolin 
Cefradiazone, Tetracycline, 
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Linezolid, Metronidazole. 
 
Meropenem,  Chloramphenicol, 
Vancomycin, Clindamycin, 
Furoxone, Nitrofurantoin, 
Septran, Sporidex. 
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Fig 1:-Armamentarium 
 
 
 
Fig 2:- Transport medium (Brain heart infusion broth and Transport cotton swab) 
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Fig 3:- Nutrient Agar plate, Maconkey’s agar plate, Blood agar plate 
 
Fig 4:- Mueller Hinton Agar, Blood Agar, MacConkey Agar, and Nutrient Agar, 
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Fig 5:-Flame sterile wire loop                       Fig 6:- Inoculation into the blood agar plate 
 
 
 
Fig 7:- Streaking                                                     Fig 8:- Gram staining 
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Fig 9:- Incubator 
 
 
Fig 10:- Incubator with media plates and transport media 
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Fig 11:- Anaerobic Jar 
 
Fig 12:- Gas Pack 
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Fig 13:- Gas Pack with indicator tablet 
 
Fig 14:- Anaerobic jar with media plates 
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Fig 15:- Indole test- Negative and Positive     Fig 16:- Triple sugar iron test- Negative and    
Positive 
                    
Fig 17:- Mannitol motility test- Negative and     Fig 18:- Citrate test- Negative and Positive 
                Positive. 
Figures 
 
  XXXVIII 
 
    
Fig 19:- Urase test- Negative and Positive       Fig 20:- Coagulase test- Negative and 
Positive 
 
 
Fig 21:- E.Coli 
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Fig 22:- Klebsiella Pneumonia 
 
 
Fig 23:- Pseudomonas Aerogenosa 
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Fig 24:- Staphylococcus aureus 
 
Fig 25:- Streptococcus viridians 
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Fig 26:- Streptococcus Viridans- Optochin confirmation test 
 
Fig 27:- Mueller Hinton Agar plate with Antimicrobial disc showing antibiotic 
sensitivity 
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Case no-1 
              
Fig 28:-Vestibular  space infection                          Fig 29:- Administering local anesthesia 
 
 
            
Fig 30:- Intraoral incision                   Fig 31:- collection of pus sample with swab 
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Case no-2 
             
Fig 32:-Vestibular space infection                         Fig 33:- Administering local anesthesia 
 
              
Fig 34:- Aspiration of pus sample               Fig 35:- Pus sample transferred into the     
                                                               transport media 
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Case History Performa 
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Case History Performa 
 
Name   :  
Age/Sex  :  
O.P.No  :  
Address  : 
Chief complaint    :   
History of Present Illness (HOPI):  
Past Medical History: 
Past dental History: 
History of drug allergy:   
General Examination: 
Extra/Intra oral   Examination: 
Provisional Diagnosis: 
Treatment done: 
 
